Sean.ndt的个人主页 - 老虎社区

Sean.ndt

Sean.ndt

暂无个人介绍

IP属地：未知

80关注

13粉丝

0主题

0勋章

2021-12-06

[Smile] [Smile]

5 Warren Buffett Stocks Are Screaming Buys in December

2021-12-01

[Miser]

NIO and Li Auto stocks jumped 5% in premarket trading

2021-11-29

Thanks for the news

Toplines Before US Market Open on Monday

2021-11-29

Thanks

5 Stocks To Watch For November 29, 2021

2021-11-29

$SINGAPORE AIRLINES LTD(C6L.SI)$Been diving man!!!

2021-11-27

Good for who bought vaccine shares

Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.

2021-11-26

Oh no, new variant dramatic spike in cases. Please take care and stay safe my South African friends

抱歉，原内容已删除

2021-11-26

Ikr

Singapore launches vaccinated travel lanes with Thailand, Cambodia, Fiji, Maldives, Sri Lanka and Turkey

2021-11-25

Ok

抱歉，原内容已删除

2021-11-25

$AMD(AMD)$Yeyyy

2021-11-24

$Alibaba(BABA)$It’s time, now or never

2021-11-23

$NIO Inc.(NIO)$Earning for nasi lemak

2021-11-19

Faster buy?

Moderna Announces FDA Authorization of Booster Dose of COVID-19 Vaccine in the U.S. for Adults 18 Years and Older

2021-11-19

$SINGAPORE AIRLINES LTD(C6L.SI)$Deep dip

2021-11-18

Thanks for info

Tired of Rivian and Lucid? 3 Better Growth Stocks to Buy Now

2021-11-18

[Sick]

抱歉，原内容已删除

2021-11-17

$AMD(AMD)$It’s up [Miser] [Miser] [Miser]

2021-11-16

Thank you for the good read

抱歉，原内容已删除

2021-11-16

Wow

抱歉，原内容已删除

2021-11-15

$AMD(AMD)$ my first buy yo haha

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4099220912746340","uuid":"4099220912746340","gmtCreate":1636117846921,"gmtModify":1636552204716,"name":"Sean.ndt","pinyin":"seanndtseanndt","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":13,"headSize":80,"tweetSize":21,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"60.92%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":608655273,"gmtCreate":1638720881442,"gmtModify":1638720881598,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"[Smile]&nbsp;[Smile]&nbsp;","listText":"[Smile]&nbsp;[Smile]&nbsp;","text":"[Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608655273","repostId":"2188528084","repostType":4,"repost":{"id":"2188528084","kind":"highlight","pubTimestamp":1638543717,"share":"https://ttm.financial/m/news/2188528084?lang=&edition=full","pubTime":"2021-12-03 23:01","market":"us","language":"en","title":"5 Warren Buffett Stocks Are Screaming Buys in December","url":"https://stock-news.laohu8.com/highlight/detail?id=2188528084","media":"Motley Fool","summary":"Riding the Oracle of Omaha's coattails is often a moneymaking proposition.","content":"<p>Making money for shareholders has been in Warren Buffett's blood since taking over as CEO of <b>Berkshire Hathaway</b> (NYSE:BRK.A)(NYSE:BRK.B) in 1965. Over that time, he's led Berkshire to an average annual gain of about 20%, which translates into aggregate gains, including the year-to-date performance of the Class A shares (BRK.A), of approximately 3,500,000%. Gains like this are why the investing world pays close attention to what the Oracle of Omaha is buying and selling.</p>\n<p>Based on the latest 13F filing with the Securities and Exchange Commission, Berkshire Hathaway has stakes in 45 securities. Among these 45 holdings, five Warren Buffett stocks stand out as screaming buys in December.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e92116e97f06291ec28eda85974acb1b\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Berkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.</span></p>\n<h2>Amazon</h2>\n<p>While I'm well aware this isn't going to win any points for originality, e-commerce kingpin <b>Amazon</b> (NASDAQ:AMZN) remains a surefire stock to own in Buffett's portfolio.</p>\n<p>Most people are familiar with Amazon for its dominant online marketplace. According to an August report from eMarketer, Amazon is expected to handle 41.4% of all U.S. online sales in 2021. That's about 34 percentage points higher than the next-closest competitor. The key, though, is that the company has signed up 200 million people to a Prime membership worldwide. The annual fees collected from these members helps to buoy razor-thin retail margins and allows Amazon to consistently undercut brick-and-mortar retailers on price.</p>\n<p>However, the company's future rests with its considerably higher-margin segments, such as cloud infrastructure services. Amazon Web Services (AWS) accounted for only 13.4% of net sales in the third quarter, yet contributed 61.8% of the company's operating income. Even with online sales slowing as coronavirus vaccination rates tick higher and life returns to some semblance of normal, Amazon's critical highest-margin segments (AWS, subscriptions, and advertising) continue to grow rapidly.</p>\n<p>If Amazon were to simply hit the median price-to-operating cash flow it's been trading at for the past 11 years, we could be looking at a $10,000 a share company by mid-decade.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b18b49b2b35da2fc49e0a83b883d1c22\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Bristol Myers Squibb</h2>\n<p>Another Warren Buffett stock that's quickly become a screaming buy is pharmaceutical company <b>Bristol Myers Squibb</b> (NYSE:BMY).</p>\n<p>Bristol Myers' success is dependent on organically developing and growing its brand-name pharmaceutical portfolio, as well as leaning on acquisitions to push the needle higher.</p>\n<p>From an internal development perspective, some of the company's biggest wins include cancer immunotherapy Opdivo and oral anticoagulant Eliquis -- the latter of which was developed with <b>Pfizer</b>. Eliquis should push for $10 billion in sales for Bristol Myers this year, while Opdivo hit $7 billion in revenue last year. Opdivo is particularly intriguing given that it's being examined in dozens of clinical trials and has already received approval for 10 indications in the U.S. Label expansion opportunities, pricing power, and improved cancer screening diagnostics all have the potential to make this a $10 billion a year therapy.</p>\n<p>Bristol Myers also made waves with its November 2019 acquisition of cancer and immunology drugmaker Celgene. Buying Celgene added a handful of blockbuster drugs to Bristol's portfolio, including multiple myeloma treatment Revlimid, which will potentially top $13 billion in 2021 sales. Revlimid is protected from an onslaught of generic competition for four more years, which means Bristol Myers will be generating bountiful cash flow in the meantime.</p>\n<p>At just 7 times consensus forward-year earnings per share, it's an absolute steal.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a295212aa2b7c99c921b8afa2a4aa3a2\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/V\">Visa</a></h2>\n<p>The recent sell-off in payment processing behemoth <b>Visa</b> (NYSE:V) makes it a screaming buy, too.</p>\n<p>Over the past couple of months, Wall Street and investors have raised concerns about payment facilitators like <b>Square</b>&nbsp;or cryptocurrencies eating into Visa's dominance. However, these concerns seem unfounded given Visa's utter dominance of the processing space. As of 2018, it held a 53% share of U.S. credit card network purchase volume, which was more than 30 percentage points higher than the next-closest competitor. I should also mention the U.S. is the leading market for consumption in the world.</p>\n<p>Visa's outperformance is also a function of its lending avoidance. By sticking to the processing side of the equation, the company avoids having to set aside capital to cover credit delinquencies during recessions. Not having to cover credit/loan losses is a big reason why Visa rebounds faster than other financial stocks and maintains a profit margin north of 50%.</p>\n<p>And have I mentioned that Visa is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the smartest ways to play rapidly rising inflation? Since the company's fees are tied to the price of goods and services, its revenue and profits will grow as the price for goods and services rises.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1c5a0257bdd17a5ff3cf22a10de43ce0\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Teva Pharmaceutical Industries</h2>\n<p>The cheapest stock in Warren Buffett's portfolio, brand-name and generic-drug company <b>Teva Pharmaceutical Industries</b> (NYSE:TEVA), is begging to be bought as well. Teva can currently be purchased for a little more than 3 times Wall Street's consensus earnings per share in 2021 and 2022.</p>\n<p>Unlike Amazon, Bristol Myers, and Visa, Teva hasn't been firing on all cylinders. Since 2016, the company settled a bribery scandal, buried itself in debt after overpaying for generic-drugmaker Actavis, and has faced a mountain of litigation concerning its role in the opioid epidemic. But while there's reason to not give Teva a valuation premium, an earnings multiple of 3 is overly pessimistic given the steps being taken to right the ship.</p>\n<p>In late 2017, Kare Schultz took over as CEO. He's a turnaround specialist who's taken clear steps to improve the business. During his tenure, net debt has been reduced from over $34 billion to around $22 billion, and annual operating expenses have been cut by a double-digit percentage. Teva is leaner than it's been in years and is capable of maintaining annual operating cash flow of $2 billion (or higher).</p>\n<p>Furthermore, there's light at the end of the tunnel when it comes to opioid litigation. A trial in California recently went in favor of drugmakers, which could put some bargaining power back in Teva's court. If Schultz can negotiate a national settlement where free or reduced-cost medicine, not cash, is the lure, Teva could probably double very quickly.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7343c3ce7330b86321a8ec9384d4baea\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Bank of America</h2>\n<p>The final Warren Buffett stock to buy hand over fist in December is banking juggernaut <b>Bank of America</b> (NYSE:BAC).</p>\n<p>Bank stocks like BofA are on the cusp of hitting their growth sweet spot. With inflation picking up, the Federal Reserve will more than likely need to act in 2022 or 2023 to raise interest rates. Boosting the federal funds target rate will lift the net interest income-earning potential of banks with outstanding variable-rate loans.</p>\n<p>Among money-center banks, none is more interest-sensitive than Bank of America. The company's third-quarter earnings presentation points out that a 100-basis-point parallel shift in the interest rate yield curve would generate an estimated $7.2 billion in added net interest income over 12 months. Although we're unlikely to see a 100-basis-point shift in 12 months, we are on the verge of seeing higher interest rates significantly bolster BofA's profit potential.</p>\n<p>The other impressive aspect of Warren Buffett's second-largest holding is its digitization efforts. Though you probably don't think of Bank of America as a tech-savvy business, the number of digital active users has grown to nearly 41 million, with 43% of all sales in the third quarter coming from online or mobile banking. This push to digitize has allowed the company to consolidate some of its branches in order to reduce costs.</p>\n<p>Bank of America should be a no-brainer buy as it enters the sweet spot of its growth cycle.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Warren Buffett Stocks Are Screaming Buys in December</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Warren Buffett Stocks Are Screaming Buys in December\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/03/5-warren-buffett-stocks-screaming-buys-in-december/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Making money for shareholders has been in Warren Buffett's blood since taking over as CEO of Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) in 1965. Over that time, he's led Berkshire to an average ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/03/5-warren-buffett-stocks-screaming-buys-in-december/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4535":"淡马锡持仓","BK4106":"数据处理与外包服务","BK4557":"大麻股","BAC":"美国银行","BK4538":"云计算","BK4559":"巴菲特持仓","BK4504":"桥水持仓","V":"Visa","BK4550":"红杉资本持仓","BK4507":"流媒体概念","BK4548":"巴美列捷福持仓","BRK.B":"伯克希尔B","BK4007":"制药","BK4551":"寇图资本持仓","BK4207":"综合性银行","BMY":"施贵宝","BK4561":"索罗斯持仓","BK4524":"宅经济概念","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","TEVA":"梯瓦制药","BK4527":"明星科技股","BK4553":"喜马拉雅资本持仓","BRK.A":"伯克希尔","BK4534":"瑞士信贷持仓","BK4503":"景林资产持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4122":"互联网与直销零售","BK4176":"多领域控股","BK4566":"资本集团","AMZN":"亚马逊"},"source_url":"https://www.fool.com/investing/2021/12/03/5-warren-buffett-stocks-screaming-buys-in-december/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188528084","content_text":"Making money for shareholders has been in Warren Buffett's blood since taking over as CEO of Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) in 1965. Over that time, he's led Berkshire to an average annual gain of about 20%, which translates into aggregate gains, including the year-to-date performance of the Class A shares (BRK.A), of approximately 3,500,000%. Gains like this are why the investing world pays close attention to what the Oracle of Omaha is buying and selling.\nBased on the latest 13F filing with the Securities and Exchange Commission, Berkshire Hathaway has stakes in 45 securities. Among these 45 holdings, five Warren Buffett stocks stand out as screaming buys in December.\nBerkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.\nAmazon\nWhile I'm well aware this isn't going to win any points for originality, e-commerce kingpin Amazon (NASDAQ:AMZN) remains a surefire stock to own in Buffett's portfolio.\nMost people are familiar with Amazon for its dominant online marketplace. According to an August report from eMarketer, Amazon is expected to handle 41.4% of all U.S. online sales in 2021. That's about 34 percentage points higher than the next-closest competitor. The key, though, is that the company has signed up 200 million people to a Prime membership worldwide. The annual fees collected from these members helps to buoy razor-thin retail margins and allows Amazon to consistently undercut brick-and-mortar retailers on price.\nHowever, the company's future rests with its considerably higher-margin segments, such as cloud infrastructure services. Amazon Web Services (AWS) accounted for only 13.4% of net sales in the third quarter, yet contributed 61.8% of the company's operating income. Even with online sales slowing as coronavirus vaccination rates tick higher and life returns to some semblance of normal, Amazon's critical highest-margin segments (AWS, subscriptions, and advertising) continue to grow rapidly.\nIf Amazon were to simply hit the median price-to-operating cash flow it's been trading at for the past 11 years, we could be looking at a $10,000 a share company by mid-decade.\nImage source: Getty Images.\nBristol Myers Squibb\nAnother Warren Buffett stock that's quickly become a screaming buy is pharmaceutical company Bristol Myers Squibb (NYSE:BMY).\nBristol Myers' success is dependent on organically developing and growing its brand-name pharmaceutical portfolio, as well as leaning on acquisitions to push the needle higher.\nFrom an internal development perspective, some of the company's biggest wins include cancer immunotherapy Opdivo and oral anticoagulant Eliquis -- the latter of which was developed with Pfizer. Eliquis should push for $10 billion in sales for Bristol Myers this year, while Opdivo hit $7 billion in revenue last year. Opdivo is particularly intriguing given that it's being examined in dozens of clinical trials and has already received approval for 10 indications in the U.S. Label expansion opportunities, pricing power, and improved cancer screening diagnostics all have the potential to make this a $10 billion a year therapy.\nBristol Myers also made waves with its November 2019 acquisition of cancer and immunology drugmaker Celgene. Buying Celgene added a handful of blockbuster drugs to Bristol's portfolio, including multiple myeloma treatment Revlimid, which will potentially top $13 billion in 2021 sales. Revlimid is protected from an onslaught of generic competition for four more years, which means Bristol Myers will be generating bountiful cash flow in the meantime.\nAt just 7 times consensus forward-year earnings per share, it's an absolute steal.\nImage source: Getty Images.\nVisa\nThe recent sell-off in payment processing behemoth Visa (NYSE:V) makes it a screaming buy, too.\nOver the past couple of months, Wall Street and investors have raised concerns about payment facilitators like Square or cryptocurrencies eating into Visa's dominance. However, these concerns seem unfounded given Visa's utter dominance of the processing space. As of 2018, it held a 53% share of U.S. credit card network purchase volume, which was more than 30 percentage points higher than the next-closest competitor. I should also mention the U.S. is the leading market for consumption in the world.\nVisa's outperformance is also a function of its lending avoidance. By sticking to the processing side of the equation, the company avoids having to set aside capital to cover credit delinquencies during recessions. Not having to cover credit/loan losses is a big reason why Visa rebounds faster than other financial stocks and maintains a profit margin north of 50%.\nAnd have I mentioned that Visa is one of the smartest ways to play rapidly rising inflation? Since the company's fees are tied to the price of goods and services, its revenue and profits will grow as the price for goods and services rises.\nImage source: Getty Images.\nTeva Pharmaceutical Industries\nThe cheapest stock in Warren Buffett's portfolio, brand-name and generic-drug company Teva Pharmaceutical Industries (NYSE:TEVA), is begging to be bought as well. Teva can currently be purchased for a little more than 3 times Wall Street's consensus earnings per share in 2021 and 2022.\nUnlike Amazon, Bristol Myers, and Visa, Teva hasn't been firing on all cylinders. Since 2016, the company settled a bribery scandal, buried itself in debt after overpaying for generic-drugmaker Actavis, and has faced a mountain of litigation concerning its role in the opioid epidemic. But while there's reason to not give Teva a valuation premium, an earnings multiple of 3 is overly pessimistic given the steps being taken to right the ship.\nIn late 2017, Kare Schultz took over as CEO. He's a turnaround specialist who's taken clear steps to improve the business. During his tenure, net debt has been reduced from over $34 billion to around $22 billion, and annual operating expenses have been cut by a double-digit percentage. Teva is leaner than it's been in years and is capable of maintaining annual operating cash flow of $2 billion (or higher).\nFurthermore, there's light at the end of the tunnel when it comes to opioid litigation. A trial in California recently went in favor of drugmakers, which could put some bargaining power back in Teva's court. If Schultz can negotiate a national settlement where free or reduced-cost medicine, not cash, is the lure, Teva could probably double very quickly.\nImage source: Getty Images.\nBank of America\nThe final Warren Buffett stock to buy hand over fist in December is banking juggernaut Bank of America (NYSE:BAC).\nBank stocks like BofA are on the cusp of hitting their growth sweet spot. With inflation picking up, the Federal Reserve will more than likely need to act in 2022 or 2023 to raise interest rates. Boosting the federal funds target rate will lift the net interest income-earning potential of banks with outstanding variable-rate loans.\nAmong money-center banks, none is more interest-sensitive than Bank of America. The company's third-quarter earnings presentation points out that a 100-basis-point parallel shift in the interest rate yield curve would generate an estimated $7.2 billion in added net interest income over 12 months. Although we're unlikely to see a 100-basis-point shift in 12 months, we are on the verge of seeing higher interest rates significantly bolster BofA's profit potential.\nThe other impressive aspect of Warren Buffett's second-largest holding is its digitization efforts. Though you probably don't think of Bank of America as a tech-savvy business, the number of digital active users has grown to nearly 41 million, with 43% of all sales in the third quarter coming from online or mobile banking. This push to digitize has allowed the company to consolidate some of its branches in order to reduce costs.\nBank of America should be a no-brainer buy as it enters the sweet spot of its growth cycle.","news_type":1,"symbols_score_info":{"AMZN":0.9,"BAC":0.9,"BMY":0.9,"BRK.A":0.9,"BRK.B":0.9,"TEVA":0.9,"V":0.9}},"isVote":1,"tweetType":1,"viewCount":1942,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603972346,"gmtCreate":1638360106895,"gmtModify":1638360107104,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"[Miser]&nbsp;","listText":"[Miser]&nbsp;","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603972346","repostId":"1180779617","repostType":4,"repost":{"id":"1180779617","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638349549,"share":"https://ttm.financial/m/news/1180779617?lang=&edition=full","pubTime":"2021-12-01 17:05","market":"us","language":"en","title":"NIO and Li Auto stocks jumped 5% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1180779617","media":"Tiger Newspress","summary":"NIO and Li Auto stocks jumped 5% in premarket trading after announcing bright delivery data.\n\nNIO de","content":"<p>NIO and Li Auto stocks jumped 5% in premarket trading after announcing bright delivery data.</p>\n<p><img src=\"https://static.tigerbbs.com/1fd7888d67848b24b5db338e59e75b97\" tg-width=\"853\" tg-height=\"623\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/51d2f8b4ca69c88da235c91213c41ab6\" tg-width=\"853\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p>\n<p>NIO delivered 10,878 vehicles in November 2021, representing a solid 105.6% year-over-year growth. The deliveries consisted of 2,683 ES8s, the Company’s six- or seven-seater flagship premium smart electric SUV, 4,713 ES6s, the Company’s five-seater high-performance premium smart electric SUV, and 3,482 EC6s, the Company’s five-seater premium smart electric coupe SUV. NIO has delivered 80,940 vehicles year-to-date in 2021 in total, representing a strong increase of 120.4% year-over-year. As of November 30, 2021, cumulative deliveries of the ES8, ES6 and EC6 reached 156,581 vehicles.</p>\n<p>Li Auto Inc.&nbsp;today announced that the Company delivered 13,485 Li ONEs in November 2021, representing a 190.2% year-over-year increase. Total deliveries for the eleven months ended November 30, 2021 reached 76,404, taking cumulative deliveries to 110,001.</p>\n<p>“We set a new monthly record with over 13,000 deliveries of Li ONEs in November, making Li ONE the first domestic branded premium model&nbsp;priced above RMB300,000&nbsp;in China to achieve the 10,000 monthly deliveries milestone. We are excited to see Li ONE emerge as one of the best choices for large SUV users and families in China. This impressive result reflects widespread user endorsement of our outstanding product features and performance, and we deeply appreciate our users’ recognition. Looking ahead, we will continue to create products and services that can delight our users and make ourselves proud,” said Yanan Shen, co-founder and president of Li Auto.</p>\n<p>As of November 30, 2021, the Company had 174 retail stores in 93 cities, as well as 236 servicing centers and Li Auto-authorized body and paint shops operating in 171 cities.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO and Li Auto stocks jumped 5% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO and Li Auto stocks jumped 5% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-01 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NIO and Li Auto stocks jumped 5% in premarket trading after announcing bright delivery data.</p>\n<p><img src=\"https://static.tigerbbs.com/1fd7888d67848b24b5db338e59e75b97\" tg-width=\"853\" tg-height=\"623\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/51d2f8b4ca69c88da235c91213c41ab6\" tg-width=\"853\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p>\n<p>NIO delivered 10,878 vehicles in November 2021, representing a solid 105.6% year-over-year growth. The deliveries consisted of 2,683 ES8s, the Company’s six- or seven-seater flagship premium smart electric SUV, 4,713 ES6s, the Company’s five-seater high-performance premium smart electric SUV, and 3,482 EC6s, the Company’s five-seater premium smart electric coupe SUV. NIO has delivered 80,940 vehicles year-to-date in 2021 in total, representing a strong increase of 120.4% year-over-year. As of November 30, 2021, cumulative deliveries of the ES8, ES6 and EC6 reached 156,581 vehicles.</p>\n<p>Li Auto Inc.&nbsp;today announced that the Company delivered 13,485 Li ONEs in November 2021, representing a 190.2% year-over-year increase. Total deliveries for the eleven months ended November 30, 2021 reached 76,404, taking cumulative deliveries to 110,001.</p>\n<p>“We set a new monthly record with over 13,000 deliveries of Li ONEs in November, making Li ONE the first domestic branded premium model&nbsp;priced above RMB300,000&nbsp;in China to achieve the 10,000 monthly deliveries milestone. We are excited to see Li ONE emerge as one of the best choices for large SUV users and families in China. This impressive result reflects widespread user endorsement of our outstanding product features and performance, and we deeply appreciate our users’ recognition. Looking ahead, we will continue to create products and services that can delight our users and make ourselves proud,” said Yanan Shen, co-founder and president of Li Auto.</p>\n<p>As of November 30, 2021, the Company had 174 retail stores in 93 cities, as well as 236 servicing centers and Li Auto-authorized body and paint shops operating in 171 cities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车","NIO":"蔚来"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180779617","content_text":"NIO and Li Auto stocks jumped 5% in premarket trading after announcing bright delivery data.\n\nNIO delivered 10,878 vehicles in November 2021, representing a solid 105.6% year-over-year growth. The deliveries consisted of 2,683 ES8s, the Company’s six- or seven-seater flagship premium smart electric SUV, 4,713 ES6s, the Company’s five-seater high-performance premium smart electric SUV, and 3,482 EC6s, the Company’s five-seater premium smart electric coupe SUV. NIO has delivered 80,940 vehicles year-to-date in 2021 in total, representing a strong increase of 120.4% year-over-year. As of November 30, 2021, cumulative deliveries of the ES8, ES6 and EC6 reached 156,581 vehicles.\nLi Auto Inc. today announced that the Company delivered 13,485 Li ONEs in November 2021, representing a 190.2% year-over-year increase. Total deliveries for the eleven months ended November 30, 2021 reached 76,404, taking cumulative deliveries to 110,001.\n“We set a new monthly record with over 13,000 deliveries of Li ONEs in November, making Li ONE the first domestic branded premium model priced above RMB300,000 in China to achieve the 10,000 monthly deliveries milestone. We are excited to see Li ONE emerge as one of the best choices for large SUV users and families in China. This impressive result reflects widespread user endorsement of our outstanding product features and performance, and we deeply appreciate our users’ recognition. Looking ahead, we will continue to create products and services that can delight our users and make ourselves proud,” said Yanan Shen, co-founder and president of Li Auto.\nAs of November 30, 2021, the Company had 174 retail stores in 93 cities, as well as 236 servicing centers and Li Auto-authorized body and paint shops operating in 171 cities.","news_type":1,"symbols_score_info":{"LI":0.9,"NIO":0.9}},"isVote":1,"tweetType":1,"viewCount":2279,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600448689,"gmtCreate":1638193271051,"gmtModify":1638193271226,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Thanks for the news","listText":"Thanks for the news","text":"Thanks for the news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/600448689","repostId":"1115824573","repostType":4,"repost":{"id":"1115824573","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638191842,"share":"https://ttm.financial/m/news/1115824573?lang=&edition=full","pubTime":"2021-11-29 21:17","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1115824573","media":"Tiger Newspress","summary":"U.S. stock index futures jumped on Monday as investors rushed in to take advantage of steep virus-dr","content":"<p>U.S. stock index futures jumped on Monday as investors rushed in to take advantage of steep virus-driven losses while awaiting more details on the severity of the Omicron coronavirus variant.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 226 points, or 0.65%. S&amp;P 500 e-minis were up 37 points, or 0.81% and Nasdaq 100 e-minis were up 148.75 points, or 0.93%.</p>\n<p><img src=\"https://static.tigerbbs.com/4e047384eb051a409672b8ce439d9f38\" tg-width=\"1080\" tg-height=\"392\" referrerpolicy=\"no-referrer\"></p>\n<p>Wall Street indexes had slumped between 2% and 3.5% on Friday after news of the variant triggered a global selloff, as countries introduced new travel curbs on fears it could resist vaccinations and upend a nascent economic reopening.</p>\n<p>President Joe Biden is due to update the public on the variant and the United States' response later in the day, the White House said.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Moderna</b>&nbsp;— Shares of the vaccine maker continued their rally, jumping more than 10% in early morning trading Monday after gaining 20% on Friday. On Sunday the company’s chief medical officer said Moderna&nbsp;could roll out a reformulated vaccine&nbsp;against the omicron variant of Covid early next year.</p>\n<p><b>Li Auto</b> —&nbsp;U.S.-listed shares of Li Auto rose 8.5%&nbsp;in premarket trading. Li Auto&nbsp;reported adjusted earnings of 3 cents a share from $1.21 billion in sales. Wall Street was looking for a 3-cent loss from $1.13 billion in sales. At this point, earnings are less important that sales for Li. The company is still growing rapidly. Sales in the third quarter rose more than 209% year over year.</p>\n<p><b>Tesla</b>&nbsp;—&nbsp;The German automotive news outlet Automobilwoche&nbsp;reported Monday that Tesla’s new manufacturing facility in that country will start production in December.Tesla&nbsp;shares&nbsp;rallied&nbsp;1.5%&nbsp;in premarket trading.</p>\n<p><b>Apple</b>&nbsp;—&nbsp;Apple&nbsp;rose 1.5% after HSBC raised its price target on the iPhone maker's stock.</p>\n<p><b>Airlines</b> — Major airlines ticked up as investors bought the dip following&nbsp;new travel suspensions in Asia and Europe, in response to the newly discovered omicron variant of Covid-19.United,Delta&nbsp;and&nbsp;American Airlines&nbsp;each gained about 1%, after losing about 7% Friday. Travel booking site&nbsp;Expedia&nbsp;also rose, about 2%.</p>\n<p><b>Cruise lines</b> —Carnival,Royal Caribbean Cruises&nbsp;and&nbsp;Norwegian Cruise Line Holdings&nbsp;each rose more than 3% amid the broader rebound in travel stocks from Friday’s omicron-driven sell-off.</p>\n<p><b>Allbirds</b>— Shares of the shoe manufacturer rose 2.5% after several analysts initiated coverage of the stock. Morgan Stanley and Bank of America both posted a price target of $23, implying 16% upside to Friday’s close.</p>\n<p><b>Coinbase</b>— The cryptocurrency exchange’s shares rose more than 2% as the price of bitcoin rebounded, after selling off with the broader equities market on Friday. Other crypto-related equities got a lift too, with&nbsp;Microstrategy&nbsp;rising 3.4%.Tesla&nbsp;and&nbsp;Square&nbsp;added more than 1%.</p>\n<p><b>Zoom Video</b>— Zoom shares fell almost 2%, moving in the opposite direction of travel stocks and following a 5.7% jump on Friday. Other stay-at-home stocks dipped slightly Monday morning too, including&nbsp;Peloton,Netflix&nbsp;and&nbsp;Teladoc.</p>\n<p><b>Merck</b>— The pharmaceutical company’s shares fell 1.8% after Citi downgraded its stock to neutral from buy, saying development struggles for the company’s HIV drug islatravir will hurt Merck’s long-term potential.</p>\n<p><b>Wynn Resorts,Las Vegas Sands</b>— The Macao gaming sector is lower after Alvin Chau, the head of Macau’s biggest casino junket operator, and 10 others were arrested over allegedly illegal gambling platforms targeting mainland Chinese, according to a report by the South China Morning Post.Wynn&nbsp;fell 1.9% and&nbsp;Las Vegas Sands&nbsp;fell 1.2%</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-29 21:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures jumped on Monday as investors rushed in to take advantage of steep virus-driven losses while awaiting more details on the severity of the Omicron coronavirus variant.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 226 points, or 0.65%. S&amp;P 500 e-minis were up 37 points, or 0.81% and Nasdaq 100 e-minis were up 148.75 points, or 0.93%.</p>\n<p><img src=\"https://static.tigerbbs.com/4e047384eb051a409672b8ce439d9f38\" tg-width=\"1080\" tg-height=\"392\" referrerpolicy=\"no-referrer\"></p>\n<p>Wall Street indexes had slumped between 2% and 3.5% on Friday after news of the variant triggered a global selloff, as countries introduced new travel curbs on fears it could resist vaccinations and upend a nascent economic reopening.</p>\n<p>President Joe Biden is due to update the public on the variant and the United States' response later in the day, the White House said.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Moderna</b>&nbsp;— Shares of the vaccine maker continued their rally, jumping more than 10% in early morning trading Monday after gaining 20% on Friday. On Sunday the company’s chief medical officer said Moderna&nbsp;could roll out a reformulated vaccine&nbsp;against the omicron variant of Covid early next year.</p>\n<p><b>Li Auto</b> —&nbsp;U.S.-listed shares of Li Auto rose 8.5%&nbsp;in premarket trading. Li Auto&nbsp;reported adjusted earnings of 3 cents a share from $1.21 billion in sales. Wall Street was looking for a 3-cent loss from $1.13 billion in sales. At this point, earnings are less important that sales for Li. The company is still growing rapidly. Sales in the third quarter rose more than 209% year over year.</p>\n<p><b>Tesla</b>&nbsp;—&nbsp;The German automotive news outlet Automobilwoche&nbsp;reported Monday that Tesla’s new manufacturing facility in that country will start production in December.Tesla&nbsp;shares&nbsp;rallied&nbsp;1.5%&nbsp;in premarket trading.</p>\n<p><b>Apple</b>&nbsp;—&nbsp;Apple&nbsp;rose 1.5% after HSBC raised its price target on the iPhone maker's stock.</p>\n<p><b>Airlines</b> — Major airlines ticked up as investors bought the dip following&nbsp;new travel suspensions in Asia and Europe, in response to the newly discovered omicron variant of Covid-19.United,Delta&nbsp;and&nbsp;American Airlines&nbsp;each gained about 1%, after losing about 7% Friday. Travel booking site&nbsp;Expedia&nbsp;also rose, about 2%.</p>\n<p><b>Cruise lines</b> —Carnival,Royal Caribbean Cruises&nbsp;and&nbsp;Norwegian Cruise Line Holdings&nbsp;each rose more than 3% amid the broader rebound in travel stocks from Friday’s omicron-driven sell-off.</p>\n<p><b>Allbirds</b>— Shares of the shoe manufacturer rose 2.5% after several analysts initiated coverage of the stock. Morgan Stanley and Bank of America both posted a price target of $23, implying 16% upside to Friday’s close.</p>\n<p><b>Coinbase</b>— The cryptocurrency exchange’s shares rose more than 2% as the price of bitcoin rebounded, after selling off with the broader equities market on Friday. Other crypto-related equities got a lift too, with&nbsp;Microstrategy&nbsp;rising 3.4%.Tesla&nbsp;and&nbsp;Square&nbsp;added more than 1%.</p>\n<p><b>Zoom Video</b>— Zoom shares fell almost 2%, moving in the opposite direction of travel stocks and following a 5.7% jump on Friday. Other stay-at-home stocks dipped slightly Monday morning too, including&nbsp;Peloton,Netflix&nbsp;and&nbsp;Teladoc.</p>\n<p><b>Merck</b>— The pharmaceutical company’s shares fell 1.8% after Citi downgraded its stock to neutral from buy, saying development struggles for the company’s HIV drug islatravir will hurt Merck’s long-term potential.</p>\n<p><b>Wynn Resorts,Las Vegas Sands</b>— The Macao gaming sector is lower after Alvin Chau, the head of Macau’s biggest casino junket operator, and 10 others were arrested over allegedly illegal gambling platforms targeting mainland Chinese, according to a report by the South China Morning Post.Wynn&nbsp;fell 1.9% and&nbsp;Las Vegas Sands&nbsp;fell 1.2%</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CCL":"嘉年华邮轮","LVS":"金沙集团","NCLH":"挪威邮轮","MRK":"默沙东","AAPL":"苹果","UAL":"联合大陆航空","BIRD":"Allbirds, Inc.","COIN":"Coinbase Global, Inc.","RCL":"皇家加勒比邮轮",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","AAL":"美国航空","LI":"理想汽车","ZM":"Zoom",".SPX":"S&P 500 Index","WYNN":"永利度假村","DAL":"达美航空","TSLA":"特斯拉","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115824573","content_text":"U.S. stock index futures jumped on Monday as investors rushed in to take advantage of steep virus-driven losses while awaiting more details on the severity of the Omicron coronavirus variant.\nAt 8:00 a.m. ET, Dow e-minis were up 226 points, or 0.65%. S&P 500 e-minis were up 37 points, or 0.81% and Nasdaq 100 e-minis were up 148.75 points, or 0.93%.\n\nWall Street indexes had slumped between 2% and 3.5% on Friday after news of the variant triggered a global selloff, as countries introduced new travel curbs on fears it could resist vaccinations and upend a nascent economic reopening.\nPresident Joe Biden is due to update the public on the variant and the United States' response later in the day, the White House said.\nStocks making the biggest moves premarket:\nModerna — Shares of the vaccine maker continued their rally, jumping more than 10% in early morning trading Monday after gaining 20% on Friday. On Sunday the company’s chief medical officer said Moderna could roll out a reformulated vaccine against the omicron variant of Covid early next year.\nLi Auto — U.S.-listed shares of Li Auto rose 8.5% in premarket trading. Li Auto reported adjusted earnings of 3 cents a share from $1.21 billion in sales. Wall Street was looking for a 3-cent loss from $1.13 billion in sales. At this point, earnings are less important that sales for Li. The company is still growing rapidly. Sales in the third quarter rose more than 209% year over year.\nTesla — The German automotive news outlet Automobilwoche reported Monday that Tesla’s new manufacturing facility in that country will start production in December.Tesla shares rallied 1.5% in premarket trading.\nApple — Apple rose 1.5% after HSBC raised its price target on the iPhone maker's stock.\nAirlines — Major airlines ticked up as investors bought the dip following new travel suspensions in Asia and Europe, in response to the newly discovered omicron variant of Covid-19.United,Delta and American Airlines each gained about 1%, after losing about 7% Friday. Travel booking site Expedia also rose, about 2%.\nCruise lines —Carnival,Royal Caribbean Cruises and Norwegian Cruise Line Holdings each rose more than 3% amid the broader rebound in travel stocks from Friday’s omicron-driven sell-off.\nAllbirds— Shares of the shoe manufacturer rose 2.5% after several analysts initiated coverage of the stock. Morgan Stanley and Bank of America both posted a price target of $23, implying 16% upside to Friday’s close.\nCoinbase— The cryptocurrency exchange’s shares rose more than 2% as the price of bitcoin rebounded, after selling off with the broader equities market on Friday. Other crypto-related equities got a lift too, with Microstrategy rising 3.4%.Tesla and Square added more than 1%.\nZoom Video— Zoom shares fell almost 2%, moving in the opposite direction of travel stocks and following a 5.7% jump on Friday. Other stay-at-home stocks dipped slightly Monday morning too, including Peloton,Netflix and Teladoc.\nMerck— The pharmaceutical company’s shares fell 1.8% after Citi downgraded its stock to neutral from buy, saying development struggles for the company’s HIV drug islatravir will hurt Merck’s long-term potential.\nWynn Resorts,Las Vegas Sands— The Macao gaming sector is lower after Alvin Chau, the head of Macau’s biggest casino junket operator, and 10 others were arrested over allegedly illegal gambling platforms targeting mainland Chinese, according to a report by the South China Morning Post.Wynn fell 1.9% and Las Vegas Sands fell 1.2%","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AAL":0.9,"AAPL":0.9,"BIRD":0.9,"CCL":0.9,"COIN":0.9,"DAL":0.9,"ESmain":0.9,"NQmain":0.9,"YMmain":0.9,"LI":0.9,"LVS":0.9,"MRK":0.9,"MRNA":0.9,"NCLH":0.9,"RCL":0.9,"TSLA":0.9,"UAL":0.9,"WYNN":0.9,"ZM":0.9}},"isVote":1,"tweetType":1,"viewCount":1787,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600498532,"gmtCreate":1638183100727,"gmtModify":1638183100891,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Thanks&nbsp;","listText":"Thanks&nbsp;","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600498532","repostId":"1193304775","repostType":4,"repost":{"id":"1193304775","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1638178459,"share":"https://ttm.financial/m/news/1193304775?lang=&edition=full","pubTime":"2021-11-29 17:34","market":"us","language":"en","title":"5 Stocks To Watch For November 29, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1193304775","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\nLi Auto's Q3 results beat estimates.its ","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Li Auto's Q3 results beat estimates.its&nbsp;total revenues reached $1.21 billion;deliveries reached 25,116 vehicles;gross margin reached 23.3%.Wall Street expects&nbsp;<b>Li Auto Inc.</b>&nbsp;to report a quarterly loss at $0.02 per share on revenue of $1.16 billion before the opening bell. Li Auto shares rose 5.8% to $34.29 in premarket trading&nbsp;Monday.</li>\n <li><b>Moderna, Inc.</b>, which was the second biopharma company to get authorization for a COVID-19 vaccine, is confident it will have something on the table shortly to tackle the latest virus threat. The company’s current vaccine will be tested against the new variant, and its ability to offer immunity will likely be known over the next couple of weeks, the company's chief medical officer Paul Burton reportedly said on BBC's \"Andrew Marr Show.\" Moderna shares rose 10.2% to $363.3 in premarket tradingMonday.</li>\n <li>Analysts are expecting&nbsp;<b>StoneX Group Inc.</b>&nbsp;to have earned $1.44 per share on revenue of $280.55 million for the latest quarter. The company will release earnings after the closing bell. StoneX shares dropped 3.4% to close at $66.70 on Friday.</li>\n</ul>\n<ul>\n <li><b>Tesla, Inc</b>&nbsp;will likely commence production operations at its Giga Berlin in Germany in December, Bloomberg reported, citing German magazine Automobilwoche. Tesla shares rallied more&nbsp;than&nbsp;2% to $1,106.2 in premarket tradingMonday.</li>\n <li>Frontline's Q3 results missed estimates.Analysts expect&nbsp;<b>Frontline Ltd.</b>&nbsp;to post a quarterly loss at $1.58 per share on revenue of $605.57 million before the opening bell. Frontline shares dropped 2.8% to&nbsp;$6.61 in premarket tradingMonday.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For November 29, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For November 29, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-11-29 17:34</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Li Auto's Q3 results beat estimates.its&nbsp;total revenues reached $1.21 billion;deliveries reached 25,116 vehicles;gross margin reached 23.3%.Wall Street expects&nbsp;<b>Li Auto Inc.</b>&nbsp;to report a quarterly loss at $0.02 per share on revenue of $1.16 billion before the opening bell. Li Auto shares rose 5.8% to $34.29 in premarket trading&nbsp;Monday.</li>\n <li><b>Moderna, Inc.</b>, which was the second biopharma company to get authorization for a COVID-19 vaccine, is confident it will have something on the table shortly to tackle the latest virus threat. The company’s current vaccine will be tested against the new variant, and its ability to offer immunity will likely be known over the next couple of weeks, the company's chief medical officer Paul Burton reportedly said on BBC's \"Andrew Marr Show.\" Moderna shares rose 10.2% to $363.3 in premarket tradingMonday.</li>\n <li>Analysts are expecting&nbsp;<b>StoneX Group Inc.</b>&nbsp;to have earned $1.44 per share on revenue of $280.55 million for the latest quarter. The company will release earnings after the closing bell. StoneX shares dropped 3.4% to close at $66.70 on Friday.</li>\n</ul>\n<ul>\n <li><b>Tesla, Inc</b>&nbsp;will likely commence production operations at its Giga Berlin in Germany in December, Bloomberg reported, citing German magazine Automobilwoche. Tesla shares rallied more&nbsp;than&nbsp;2% to $1,106.2 in premarket tradingMonday.</li>\n <li>Frontline's Q3 results missed estimates.Analysts expect&nbsp;<b>Frontline Ltd.</b>&nbsp;to post a quarterly loss at $1.58 per share on revenue of $605.57 million before the opening bell. Frontline shares dropped 2.8% to&nbsp;$6.61 in premarket tradingMonday.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车","MRNA":"Moderna, Inc.","SNEX":"StoneX Group Inc.","TSLA":"特斯拉","FRO":"FRONTLINE PLC"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193304775","content_text":"Some of the stocks that may grab investor focus today are:\n\nLi Auto's Q3 results beat estimates.its total revenues reached $1.21 billion;deliveries reached 25,116 vehicles;gross margin reached 23.3%.Wall Street expects Li Auto Inc. to report a quarterly loss at $0.02 per share on revenue of $1.16 billion before the opening bell. Li Auto shares rose 5.8% to $34.29 in premarket trading Monday.\nModerna, Inc., which was the second biopharma company to get authorization for a COVID-19 vaccine, is confident it will have something on the table shortly to tackle the latest virus threat. The company’s current vaccine will be tested against the new variant, and its ability to offer immunity will likely be known over the next couple of weeks, the company's chief medical officer Paul Burton reportedly said on BBC's \"Andrew Marr Show.\" Moderna shares rose 10.2% to $363.3 in premarket tradingMonday.\nAnalysts are expecting StoneX Group Inc. to have earned $1.44 per share on revenue of $280.55 million for the latest quarter. The company will release earnings after the closing bell. StoneX shares dropped 3.4% to close at $66.70 on Friday.\n\n\nTesla, Inc will likely commence production operations at its Giga Berlin in Germany in December, Bloomberg reported, citing German magazine Automobilwoche. Tesla shares rallied more than 2% to $1,106.2 in premarket tradingMonday.\nFrontline's Q3 results missed estimates.Analysts expect Frontline Ltd. to post a quarterly loss at $1.58 per share on revenue of $605.57 million before the opening bell. Frontline shares dropped 2.8% to $6.61 in premarket tradingMonday.","news_type":1,"symbols_score_info":{"FRO":0.9,"LI":0.9,"MRNA":0.9,"SNEX":0.9,"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":3047,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600652666,"gmtCreate":1638149944581,"gmtModify":1638149944706,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Been diving man!!!","listText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Been diving man!!!","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$Been diving man!!!","images":[{"img":"https://static.tigerbbs.com/891f0a3274e37f0627bc3d875fd913fa","width":"1125","height":"2312"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600652666","isVote":1,"tweetType":1,"viewCount":1921,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":877409950,"gmtCreate":1637966463487,"gmtModify":1637966463586,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Good for who bought vaccine shares&nbsp;","listText":"Good for who bought vaccine shares&nbsp;","text":"Good for who bought vaccine shares","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877409950","repostId":"1125886564","repostType":4,"repost":{"id":"1125886564","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637938179,"share":"https://ttm.financial/m/news/1125886564?lang=&edition=full","pubTime":"2021-11-26 22:49","market":"us","language":"en","title":"Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1125886564","media":"Tiger Newspress","summary":"Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23% and BioNTech ","content":"<p>Vaccine&nbsp;stocks&nbsp;continued&nbsp;to&nbsp;rise&nbsp;in&nbsp;early&nbsp;trading,&nbsp;Moderna&nbsp;shares&nbsp;surged&nbsp;more&nbsp;than&nbsp;23%&nbsp;and&nbsp;BioNTech&nbsp;jumped&nbsp;nearly&nbsp;19%.<img src=\"https://static.tigerbbs.com/2e9f40662925ec57d0176cf5f1e36df4\" tg-width=\"876\" tg-height=\"613\" referrerpolicy=\"no-referrer\">Germany's BioNTech &nbsp;said it is studying the effectiveness of its COVID-19 vaccine against the new B.1.1.529 variant detected in South Africa - The Economic Times.</p>\n<p>\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" a BioNTech spokesperson said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-26 22:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine&nbsp;stocks&nbsp;continued&nbsp;to&nbsp;rise&nbsp;in&nbsp;early&nbsp;trading,&nbsp;Moderna&nbsp;shares&nbsp;surged&nbsp;more&nbsp;than&nbsp;23%&nbsp;and&nbsp;BioNTech&nbsp;jumped&nbsp;nearly&nbsp;19%.<img src=\"https://static.tigerbbs.com/2e9f40662925ec57d0176cf5f1e36df4\" tg-width=\"876\" tg-height=\"613\" referrerpolicy=\"no-referrer\">Germany's BioNTech &nbsp;said it is studying the effectiveness of its COVID-19 vaccine against the new B.1.1.529 variant detected in South Africa - The Economic Times.</p>\n<p>\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" a BioNTech spokesperson said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125886564","content_text":"Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23% and BioNTech jumped nearly 19%.Germany's BioNTech  said it is studying the effectiveness of its COVID-19 vaccine against the new B.1.1.529 variant detected in South Africa - The Economic Times.\n\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" a BioNTech spokesperson said.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":2061,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877863924,"gmtCreate":1637914268794,"gmtModify":1637914268859,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Oh no, new variant dramatic spike in cases. Please take care and stay safe my South African friends","listText":"Oh no, new variant dramatic spike in cases. Please take care and stay safe my South African friends","text":"Oh no, new variant dramatic spike in cases. Please take care and stay safe my South African friends","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877863924","repostId":"2186316305","repostType":4,"isVote":1,"tweetType":1,"viewCount":1774,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877884326,"gmtCreate":1637913166079,"gmtModify":1637913166151,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Ikr","listText":"Ikr","text":"Ikr","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877884326","repostId":"1132624780","repostType":2,"repost":{"id":"1132624780","kind":"news","pubTimestamp":1637910459,"share":"https://ttm.financial/m/news/1132624780?lang=&edition=full","pubTime":"2021-11-26 15:07","market":"sg","language":"en","title":"Singapore launches vaccinated travel lanes with Thailand, Cambodia, Fiji, Maldives, Sri Lanka and Turkey","url":"https://stock-news.laohu8.com/highlight/detail?id=1132624780","media":"CNA","summary":"Singapore will extend vaccinated travel lanes (VTLs) to six more countries next month, the Civil Avi","content":"<p>Singapore will extend vaccinated travel lanes (VTLs) to six more countries next month,&nbsp;the Civil Aviation Authority of Singapore (CAAS) announced on Friday (Nov 26).</p>\n<p>From Dec 14, travellers from Thailand may enter Singapore under the quarantine-free VTL.</p>\n<p>Travellers from&nbsp;Cambodia, Fiji, Maldives, Sri Lanka and Turkey can do so&nbsp;from Dec 16.</p>\n<p>This&nbsp;latest move will increase the number of countries with which Singapore has VTL arrangements to 27.</p>\n<p>Before the COVID-19 pandemic, these&nbsp;27 countries contributed to about 60 per cent of the total daily arrivals at Changi Airport, said CAAS.</p>\n<p>\"This latest extension will further broaden Changi’s network and help reclaim and rebuild Singapore's status as an international aviation hub with global connectivity,\" said the authority.</p>\n<p>Under the VTL scheme, fully vaccinated travellers on designated VTL flights&nbsp;can enter Singapore without undergoing quarantine. They are only required to undergo COVID-19 testing.</p>\n<p>\"The expansion of the VTL scheme to these countries will continue to restore two-way quarantine-free travel between Singapore and VTL countries whose borders are now open to us,\" said CAAS.</p>\n<p><b>RESTRICTIONS TIGHTENED FOR SOME COUNTRIES</b></p>\n<p>Singapore will classify&nbsp;Austria, Belgium, Croatia, the Czech Republic, Liechtenstein and Slovakia as Category III countries from 11.59pm on Dec 1, the Ministry of Health (MOH) said in a separate news release.</p>\n<p>This follows the \"worsening situation\" in the six European countries, MOH said.</p>\n<p>Travellers from Category III countries are required to serve a 10-day stay-home notice at their place of accommodation, in addition to COVID-19 testing.</p>","source":"can_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore launches vaccinated travel lanes with Thailand, Cambodia, Fiji, Maldives, Sri Lanka and Turkey</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore launches vaccinated travel lanes with Thailand, Cambodia, Fiji, Maldives, Sri Lanka and Turkey\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 15:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.channelnewsasia.com/singapore/vtl-thailand-cambodia-maldives-singapore-vaccinated-travel-lane-covid19-2340016><strong>CNA</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Singapore will extend vaccinated travel lanes (VTLs) to six more countries next month, the Civil Aviation Authority of Singapore (CAAS) announced on Friday (Nov 26).\nFrom Dec 14, travellers from ...</p>\n\n<a href=\"https://www.channelnewsasia.com/singapore/vtl-thailand-cambodia-maldives-singapore-vaccinated-travel-lane-covid19-2340016\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数","C6L.SI":"新加坡航空公司"},"source_url":"https://www.channelnewsasia.com/singapore/vtl-thailand-cambodia-maldives-singapore-vaccinated-travel-lane-covid19-2340016","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132624780","content_text":"Singapore will extend vaccinated travel lanes (VTLs) to six more countries next month, the Civil Aviation Authority of Singapore (CAAS) announced on Friday (Nov 26).\nFrom Dec 14, travellers from Thailand may enter Singapore under the quarantine-free VTL.\nTravellers from Cambodia, Fiji, Maldives, Sri Lanka and Turkey can do so from Dec 16.\nThis latest move will increase the number of countries with which Singapore has VTL arrangements to 27.\nBefore the COVID-19 pandemic, these 27 countries contributed to about 60 per cent of the total daily arrivals at Changi Airport, said CAAS.\n\"This latest extension will further broaden Changi’s network and help reclaim and rebuild Singapore's status as an international aviation hub with global connectivity,\" said the authority.\nUnder the VTL scheme, fully vaccinated travellers on designated VTL flights can enter Singapore without undergoing quarantine. They are only required to undergo COVID-19 testing.\n\"The expansion of the VTL scheme to these countries will continue to restore two-way quarantine-free travel between Singapore and VTL countries whose borders are now open to us,\" said CAAS.\nRESTRICTIONS TIGHTENED FOR SOME COUNTRIES\nSingapore will classify Austria, Belgium, Croatia, the Czech Republic, Liechtenstein and Slovakia as Category III countries from 11.59pm on Dec 1, the Ministry of Health (MOH) said in a separate news release.\nThis follows the \"worsening situation\" in the six European countries, MOH said.\nTravellers from Category III countries are required to serve a 10-day stay-home notice at their place of accommodation, in addition to COVID-19 testing.","news_type":1,"symbols_score_info":{"C6L.SI":0.9,"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":2140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877076195,"gmtCreate":1637852078062,"gmtModify":1637852078167,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877076195","repostId":"1119170686","repostType":4,"isVote":1,"tweetType":1,"viewCount":2017,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874534427,"gmtCreate":1637800235986,"gmtModify":1637800241574,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>Yeyyy","listText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>Yeyyy","text":"$AMD(AMD)$Yeyyy","images":[{"img":"https://static.tigerbbs.com/3873bf4e608fb5824cbc4ef85c2b6d50","width":"1125","height":"2877"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874534427","isVote":1,"tweetType":1,"viewCount":2651,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":874811472,"gmtCreate":1637755650998,"gmtModify":1637755651064,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>It’s time, now or never","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>It’s time, now or never","text":"$Alibaba(BABA)$It’s time, now or never","images":[{"img":"https://static.tigerbbs.com/d6e05e9e34db0343fa31df5b96c9ac83","width":"1125","height":"3138"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874811472","isVote":1,"tweetType":1,"viewCount":519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":875159397,"gmtCreate":1637627069416,"gmtModify":1637627069502,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NIO\">$NIO Inc.(NIO)$</a>Earning for nasi lemak","listText":"<a href=\"https://laohu8.com/S/NIO\">$NIO Inc.(NIO)$</a>Earning for nasi lemak","text":"$NIO Inc.(NIO)$Earning for nasi lemak","images":[{"img":"https://static.tigerbbs.com/ed77cae44f1f18fcb3c372b35d067e09","width":"1170","height":"2292"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875159397","isVote":1,"tweetType":1,"viewCount":646,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":876532687,"gmtCreate":1637330452218,"gmtModify":1637330452366,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Faster buy?","listText":"Faster buy?","text":"Faster buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876532687","repostId":"1138047553","repostType":4,"repost":{"id":"1138047553","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637327403,"share":"https://ttm.financial/m/news/1138047553?lang=&edition=full","pubTime":"2021-11-19 21:10","market":"us","language":"en","title":"Moderna Announces FDA Authorization of Booster Dose of COVID-19 Vaccine in the U.S. for Adults 18 Years and Older","url":"https://stock-news.laohu8.com/highlight/detail?id=1138047553","media":"Tiger Newspress","summary":"Moderna stock surged 4% in premarket trading after announcing FDA authorization of booster dose of C","content":"<p>Moderna stock surged 4% in premarket trading&nbsp;after announcing FDA authorization of booster dose of COVID-19 Vaccine in the U.S. for adults 18 years and older.</p>\n<p><img src=\"https://static.tigerbbs.com/b8db683899273d344e819a53f4b3366b\" tg-width=\"850\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna, Inc.&nbsp;today announced that theU.S. Food and Drug Administration(FDA) has extended the emergency use authorization of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level to all adults aged 18 and older. This booster can be used in all individuals 18 years and older who have completed a primary vaccination with any other authorized or approved COVID-19 vaccine.</p>\n<p>“This emergency use authorization comes at a critical time as we enter the winter months and face increasing COVID-19 case counts and hospitalizations across the country,” saidStéphane Bancel, Chief Executive Officer ofModerna. “We thank the FDA for their review, and are confident in the robust clinical evidence that a 50 µg booster dose of mRNA-1273 induces a strong immune response against COVID-19.”</p>\n<p>The booster dose is to be administered at least six months after completion of any primary series COVID-19 vaccination. OnOctober 20th, the FDAauthorizedfor emergency use a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level for people aged 65 and older as well as adults aged 18 to 64 who are at high risk of severe COVID-19; and people aged 18 to 64 with frequent institutional or occupational exposure to SARS-CoV-2. The Moderna COVID-19 booster vaccine is authorized for adults ages 18 and above regardless of occupational risk factors in many international markets. This follows the earlier approval of the 100 µg mRNA 1273 third dose in immunocompromised individuals.</p>\n<p>The FDA based this EUA on the totality of scientific evidence shared by the company including a data analysis from the Phase 2 clinical study of mRNA-1273, which was amended to offer a booster dose of mRNA-1273 at the 50 µg dose level to interested participants 6-8 months following their second dose (n=344). Neutralizing antibody titers had waned prior to boosting, particularly against variants of concern, at approximately 6 months. Notably, a booster dose of mRNA-1273 at the 50 µg dose level boosted neutralizing titers significantly above the Phase 3 benchmark. The safety profile following the booster dose was similar to that observed previously for dose 2 of mRNA-1273.</p>\n<p>As a next step, theU.S. Centers for Disease Controland Prevention’s (CDC)&nbsp;Advisory Committee on Immunization Practices(ACIP) will meet to discuss a potential recommendation for rollout of COVID-19 boosters to Americans.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Announces FDA Authorization of Booster Dose of COVID-19 Vaccine in the U.S. for Adults 18 Years and Older</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Announces FDA Authorization of Booster Dose of COVID-19 Vaccine in the U.S. for Adults 18 Years and Older\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-19 21:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna stock surged 4% in premarket trading&nbsp;after announcing FDA authorization of booster dose of COVID-19 Vaccine in the U.S. for adults 18 years and older.</p>\n<p><img src=\"https://static.tigerbbs.com/b8db683899273d344e819a53f4b3366b\" tg-width=\"850\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna, Inc.&nbsp;today announced that theU.S. Food and Drug Administration(FDA) has extended the emergency use authorization of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level to all adults aged 18 and older. This booster can be used in all individuals 18 years and older who have completed a primary vaccination with any other authorized or approved COVID-19 vaccine.</p>\n<p>“This emergency use authorization comes at a critical time as we enter the winter months and face increasing COVID-19 case counts and hospitalizations across the country,” saidStéphane Bancel, Chief Executive Officer ofModerna. “We thank the FDA for their review, and are confident in the robust clinical evidence that a 50 µg booster dose of mRNA-1273 induces a strong immune response against COVID-19.”</p>\n<p>The booster dose is to be administered at least six months after completion of any primary series COVID-19 vaccination. OnOctober 20th, the FDAauthorizedfor emergency use a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level for people aged 65 and older as well as adults aged 18 to 64 who are at high risk of severe COVID-19; and people aged 18 to 64 with frequent institutional or occupational exposure to SARS-CoV-2. The Moderna COVID-19 booster vaccine is authorized for adults ages 18 and above regardless of occupational risk factors in many international markets. This follows the earlier approval of the 100 µg mRNA 1273 third dose in immunocompromised individuals.</p>\n<p>The FDA based this EUA on the totality of scientific evidence shared by the company including a data analysis from the Phase 2 clinical study of mRNA-1273, which was amended to offer a booster dose of mRNA-1273 at the 50 µg dose level to interested participants 6-8 months following their second dose (n=344). Neutralizing antibody titers had waned prior to boosting, particularly against variants of concern, at approximately 6 months. Notably, a booster dose of mRNA-1273 at the 50 µg dose level boosted neutralizing titers significantly above the Phase 3 benchmark. The safety profile following the booster dose was similar to that observed previously for dose 2 of mRNA-1273.</p>\n<p>As a next step, theU.S. Centers for Disease Controland Prevention’s (CDC)&nbsp;Advisory Committee on Immunization Practices(ACIP) will meet to discuss a potential recommendation for rollout of COVID-19 boosters to Americans.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138047553","content_text":"Moderna stock surged 4% in premarket trading after announcing FDA authorization of booster dose of COVID-19 Vaccine in the U.S. for adults 18 years and older.\n\nModerna, Inc. today announced that theU.S. Food and Drug Administration(FDA) has extended the emergency use authorization of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level to all adults aged 18 and older. This booster can be used in all individuals 18 years and older who have completed a primary vaccination with any other authorized or approved COVID-19 vaccine.\n“This emergency use authorization comes at a critical time as we enter the winter months and face increasing COVID-19 case counts and hospitalizations across the country,” saidStéphane Bancel, Chief Executive Officer ofModerna. “We thank the FDA for their review, and are confident in the robust clinical evidence that a 50 µg booster dose of mRNA-1273 induces a strong immune response against COVID-19.”\nThe booster dose is to be administered at least six months after completion of any primary series COVID-19 vaccination. OnOctober 20th, the FDAauthorizedfor emergency use a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level for people aged 65 and older as well as adults aged 18 to 64 who are at high risk of severe COVID-19; and people aged 18 to 64 with frequent institutional or occupational exposure to SARS-CoV-2. The Moderna COVID-19 booster vaccine is authorized for adults ages 18 and above regardless of occupational risk factors in many international markets. This follows the earlier approval of the 100 µg mRNA 1273 third dose in immunocompromised individuals.\nThe FDA based this EUA on the totality of scientific evidence shared by the company including a data analysis from the Phase 2 clinical study of mRNA-1273, which was amended to offer a booster dose of mRNA-1273 at the 50 µg dose level to interested participants 6-8 months following their second dose (n=344). Neutralizing antibody titers had waned prior to boosting, particularly against variants of concern, at approximately 6 months. Notably, a booster dose of mRNA-1273 at the 50 µg dose level boosted neutralizing titers significantly above the Phase 3 benchmark. The safety profile following the booster dose was similar to that observed previously for dose 2 of mRNA-1273.\nAs a next step, theU.S. Centers for Disease Controland Prevention’s (CDC) Advisory Committee on Immunization Practices(ACIP) will meet to discuss a potential recommendation for rollout of COVID-19 boosters to Americans.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":1062,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876846042,"gmtCreate":1637295826622,"gmtModify":1637295826689,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Deep dip","listText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Deep dip","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$Deep dip","images":[{"img":"https://static.tigerbbs.com/8833b95dc4e27a2d444ee3da5cd24b0c","width":"1125","height":"2312"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876846042","isVote":1,"tweetType":1,"viewCount":390,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":878547201,"gmtCreate":1637212717752,"gmtModify":1637212728989,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Thanks for info","listText":"Thanks for info","text":"Thanks for info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878547201","repostId":"2184853339","repostType":4,"repost":{"id":"2184853339","kind":"highlight","pubTimestamp":1637206020,"share":"https://ttm.financial/m/news/2184853339?lang=&edition=full","pubTime":"2021-11-18 11:27","market":"us","language":"en","title":"Tired of Rivian and Lucid? 3 Better Growth Stocks to Buy Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2184853339","media":"Motley Fool","summary":"Electric vehicle stocks are hot, but these industrial companies could be better buys now.","content":"<p>With everything going on in the stock market and cryptocurrency market, it's hard for <a href=\"https://laohu8.com/S/AONE.U\">one</a> story to dominate headlines for a day, much less a week. Yet that's exactly what electric vehicle (EV) stocks have done since <b>Rivian Automotive</b> (NASDAQ:RIVN) had its initial public offering (IPO) last week. After debuting at a price of $78 per share, Rivian stock has already doubled. Similarly, share prices of <b>Lucid Group</b> (NASDAQ:LCID), a luxury EV company, have more than doubled in the last month. But those gains are in the past. It's time to look at what's the best option now.</p>\n<p>Investors scanning the horizon for growth stocks may be better off taking a look at <b>Trimble</b> (NASDAQ:TRMB), <b>Array Technologies </b>(NASDAQ:ARRY), and <b>MP Materials</b> (NYSE:MP). Here's why some Fool.com contributors think each is a great buy now.</p>\n<h2>The infrastructure bill is just one of many growth drivers for Trimble</h2>\n<p><b>Lee Samaha (Trimble):</b> Trimble is a leading light in the positioning and modeling business. As such, its roots lie in the geospatial industry (mapping and surveying). The geospatial industry is still a significant end market -- making up around 23% of Trimble's third-quarter revenue. However, its largest end market is buildings and construction (39% of revenue). The other two end markets are the fast-growing resources and utilities (20% of revenue) space and transportation (18% of revenue).</p>\n<p>Trimble's solutions are increasingly used as an integral part of its customers' daily activities. For example, trucking companies use Trimble to make sure their fleets are running safely and effectively, all the time analyzing real-time data to improve performance. In agriculture, its precision agriculture hardware and software help farmers make better decisions when it comes to planting, nurturing, and harvesting crops.</p>\n<p>Moreover, in building and construction, the company's technology helps contractors accurately complete building and infrastructure projects, and in doing so, reduce waste and carbon emissions. As such, the infrastructure bill will lead to plenty of growth opportunities as upgrading the nation's infrastructure can be achieved in a more cost-efficient and environmentally friendly way using Trimble.</p>\n<p>Given the explosion of connected devices, digital technologies, and analytics capability, it's highly likely that there will be increased adoption of positioning and modeling technology in the future. Again, Trimble is ideally placed to take advantage.</p>\n<h2>This solar stock went from cold to hot</h2>\n<p><b>Daniel Foelber&nbsp;(Array Technologies):</b> Share prices of solar tracking manufacturer Array Technologies have staged quite the comeback since falling 74% from its high in May. The company was caught completely off guard by supply chain constraints and rising raw material costs -- namely steel. The news not only stunted its growth, but crippled its margins, too.</p>\n<p>Although the company's short-term performance continues to suffer,&nbsp;it has done a good job partnering with companies like <b>Nucor</b> to secure more reliable steel pricing, as well as building a healthy backlog of projects. Although Array's Q3 figures were weak, the company's outlook for the year ahead casts a bright light that the worst of its problems may be over.</p>\n<p>Array is a great example of a growth stock that looked strong headed into 2021, suffered a lot of setbacks, and is now beginning to get back on its feet. Now is the perfect time for investors to revisit the long-term investment thesis, which centers around the growing need for more efficient and cost-effective solar tracking. Array's industry-leading technology maximizes the amount of solar energy that a panel can generate, which saves costs in the long run. The company's business is almost entirely in the U.S. but there are plans to expand internationally as new markets demand more efficient solar systems. Given the lower cost of utility-solar and estimates that solar will only grow its share in the global energy mix, Array is a growth stock worth following as its fundamentals improve.</p>\n<h2>Dig this under-the-radar EV stock</h2>\n<p><b>Scott Levine (MP Materials): </b>Soaring steeply higher in its short time as a publicly traded company, Rivian's stock is charging into the hearts -- and portfolios -- of many EV-focused investors. While the stock is currently the talk of the town, there's another EV stock that represents another great growth opportunity, though it hardly finds itself in the limelight as Rivian currently does. MP Materials is a mining company that owns and operates Mountain Pass, where it mines and processes rare earth minerals. Although lithium is the mineral that is likely most familiar to renewable energy investors, rare earth minerals are critical components in the production of magnets used in EVs and other advanced motion technologies like wind turbines and drones.</p>\n<p>The bull case for MP Materials is predicated largely on the fact that rare earth minerals are, well, <i>rare --&nbsp;</i>not something you can easily find in your backyard -- so owning and operating one of the largest integrated rare earth mining and processing facilities in the world (as MP Materials proclaims to do) is fairly compelling. Add to that the fact that the United States has voiced a desire to shore up its supply of rare earth materials by distancing itself from China, where the majority of rare earth minerals are currently sourced, and MP Materials becomes even more attractive.</p>\n<p>During an investors presentation last year, MP Materials projected that its revenue would rise at a compound annual growth rate (CAGR) of 53% from $75 million in 2019 to $415 million in 2023. But it wouldn't be surprising if the top line grows at an even greater clip than that. Through the first nine months of 2021, the company has reported revenue of $233 million, blowing past its earlier forecast of $171 million for all of 2021. Pivoting to the cash flow statement, investors will find that while this growth company has a long runway ahead of it, the company's risks are mitigated by the fact that it's cash-flow positive. Through the first nine months of 2021, MP Materials has generated operating cash flow of $70.5 million, and management expects it to become free-cash-flow positive in 2022.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tired of Rivian and Lucid? 3 Better Growth Stocks to Buy Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTired of Rivian and Lucid? 3 Better Growth Stocks to Buy Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-18 11:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/17/tired-of-rivian-and-lucid-3-better-growth-stocks-t/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With everything going on in the stock market and cryptocurrency market, it's hard for one story to dominate headlines for a day, much less a week. Yet that's exactly what electric vehicle (EV) stocks ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/17/tired-of-rivian-and-lucid-3-better-growth-stocks-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRMB":"天宝导航","ARRY":"Array Technologies Inc.","MP":"MP Materials Corp."},"source_url":"https://www.fool.com/investing/2021/11/17/tired-of-rivian-and-lucid-3-better-growth-stocks-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2184853339","content_text":"With everything going on in the stock market and cryptocurrency market, it's hard for one story to dominate headlines for a day, much less a week. Yet that's exactly what electric vehicle (EV) stocks have done since Rivian Automotive (NASDAQ:RIVN) had its initial public offering (IPO) last week. After debuting at a price of $78 per share, Rivian stock has already doubled. Similarly, share prices of Lucid Group (NASDAQ:LCID), a luxury EV company, have more than doubled in the last month. But those gains are in the past. It's time to look at what's the best option now.\nInvestors scanning the horizon for growth stocks may be better off taking a look at Trimble (NASDAQ:TRMB), Array Technologies (NASDAQ:ARRY), and MP Materials (NYSE:MP). Here's why some Fool.com contributors think each is a great buy now.\nThe infrastructure bill is just one of many growth drivers for Trimble\nLee Samaha (Trimble): Trimble is a leading light in the positioning and modeling business. As such, its roots lie in the geospatial industry (mapping and surveying). The geospatial industry is still a significant end market -- making up around 23% of Trimble's third-quarter revenue. However, its largest end market is buildings and construction (39% of revenue). The other two end markets are the fast-growing resources and utilities (20% of revenue) space and transportation (18% of revenue).\nTrimble's solutions are increasingly used as an integral part of its customers' daily activities. For example, trucking companies use Trimble to make sure their fleets are running safely and effectively, all the time analyzing real-time data to improve performance. In agriculture, its precision agriculture hardware and software help farmers make better decisions when it comes to planting, nurturing, and harvesting crops.\nMoreover, in building and construction, the company's technology helps contractors accurately complete building and infrastructure projects, and in doing so, reduce waste and carbon emissions. As such, the infrastructure bill will lead to plenty of growth opportunities as upgrading the nation's infrastructure can be achieved in a more cost-efficient and environmentally friendly way using Trimble.\nGiven the explosion of connected devices, digital technologies, and analytics capability, it's highly likely that there will be increased adoption of positioning and modeling technology in the future. Again, Trimble is ideally placed to take advantage.\nThis solar stock went from cold to hot\nDaniel Foelber (Array Technologies): Share prices of solar tracking manufacturer Array Technologies have staged quite the comeback since falling 74% from its high in May. The company was caught completely off guard by supply chain constraints and rising raw material costs -- namely steel. The news not only stunted its growth, but crippled its margins, too.\nAlthough the company's short-term performance continues to suffer, it has done a good job partnering with companies like Nucor to secure more reliable steel pricing, as well as building a healthy backlog of projects. Although Array's Q3 figures were weak, the company's outlook for the year ahead casts a bright light that the worst of its problems may be over.\nArray is a great example of a growth stock that looked strong headed into 2021, suffered a lot of setbacks, and is now beginning to get back on its feet. Now is the perfect time for investors to revisit the long-term investment thesis, which centers around the growing need for more efficient and cost-effective solar tracking. Array's industry-leading technology maximizes the amount of solar energy that a panel can generate, which saves costs in the long run. The company's business is almost entirely in the U.S. but there are plans to expand internationally as new markets demand more efficient solar systems. Given the lower cost of utility-solar and estimates that solar will only grow its share in the global energy mix, Array is a growth stock worth following as its fundamentals improve.\nDig this under-the-radar EV stock\nScott Levine (MP Materials): Soaring steeply higher in its short time as a publicly traded company, Rivian's stock is charging into the hearts -- and portfolios -- of many EV-focused investors. While the stock is currently the talk of the town, there's another EV stock that represents another great growth opportunity, though it hardly finds itself in the limelight as Rivian currently does. MP Materials is a mining company that owns and operates Mountain Pass, where it mines and processes rare earth minerals. Although lithium is the mineral that is likely most familiar to renewable energy investors, rare earth minerals are critical components in the production of magnets used in EVs and other advanced motion technologies like wind turbines and drones.\nThe bull case for MP Materials is predicated largely on the fact that rare earth minerals are, well, rare -- not something you can easily find in your backyard -- so owning and operating one of the largest integrated rare earth mining and processing facilities in the world (as MP Materials proclaims to do) is fairly compelling. Add to that the fact that the United States has voiced a desire to shore up its supply of rare earth materials by distancing itself from China, where the majority of rare earth minerals are currently sourced, and MP Materials becomes even more attractive.\nDuring an investors presentation last year, MP Materials projected that its revenue would rise at a compound annual growth rate (CAGR) of 53% from $75 million in 2019 to $415 million in 2023. But it wouldn't be surprising if the top line grows at an even greater clip than that. Through the first nine months of 2021, the company has reported revenue of $233 million, blowing past its earlier forecast of $171 million for all of 2021. Pivoting to the cash flow statement, investors will find that while this growth company has a long runway ahead of it, the company's risks are mitigated by the fact that it's cash-flow positive. Through the first nine months of 2021, MP Materials has generated operating cash flow of $70.5 million, and management expects it to become free-cash-flow positive in 2022.","news_type":1,"symbols_score_info":{"ARRY":0.9,"MP":0.9,"TRMB":0.9}},"isVote":1,"tweetType":1,"viewCount":842,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878651694,"gmtCreate":1637192185209,"gmtModify":1637192185310,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"[Sick]&nbsp;","listText":"[Sick]&nbsp;","text":"[Sick]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878651694","repostId":"2184764854","repostType":4,"isVote":1,"tweetType":1,"viewCount":865,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871417740,"gmtCreate":1637105576724,"gmtModify":1637105576820,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>It’s up [Miser]&nbsp;[Miser]&nbsp;[Miser]&nbsp;","listText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>It’s up [Miser]&nbsp;[Miser]&nbsp;[Miser]&nbsp;","text":"$AMD(AMD)$It’s up [Miser] [Miser] [Miser]","images":[{"img":"https://static.tigerbbs.com/1cac6ada29c795df9a2f6c1bae2879c9","width":"1125","height":"2791"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871417740","isVote":1,"tweetType":1,"viewCount":864,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":871156278,"gmtCreate":1637040752269,"gmtModify":1637040752269,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Thank&nbsp;you for the good read","listText":"Thank&nbsp;you for the good read","text":"Thank you for the good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871156278","repostId":"1160740007","repostType":4,"isVote":1,"tweetType":1,"viewCount":1061,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871105241,"gmtCreate":1637032749934,"gmtModify":1637032750090,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871105241","repostId":"1140879609","repostType":4,"isVote":1,"tweetType":1,"viewCount":741,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873728799,"gmtCreate":1636988325072,"gmtModify":1636988325072,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a> my first buy yo haha","listText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a> my first buy yo haha","text":"$AMD(AMD)$ my first buy yo haha","images":[{"img":"https://static.tigerbbs.com/a75ab7b55c17251b399157101e212af1","width":"1170","height":"2292"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/873728799","isVote":1,"tweetType":1,"viewCount":1465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"hots":[{"id":873728799,"gmtCreate":1636988325072,"gmtModify":1636988325072,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a> my first buy yo haha","listText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a> my first buy yo haha","text":"$AMD(AMD)$ my first buy yo haha","images":[{"img":"https://static.tigerbbs.com/a75ab7b55c17251b399157101e212af1","width":"1170","height":"2292"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/873728799","isVote":1,"tweetType":1,"viewCount":1465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":600448689,"gmtCreate":1638193271051,"gmtModify":1638193271226,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Thanks for the news","listText":"Thanks for the news","text":"Thanks for the news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/600448689","repostId":"1115824573","repostType":4,"repost":{"id":"1115824573","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638191842,"share":"https://ttm.financial/m/news/1115824573?lang=&edition=full","pubTime":"2021-11-29 21:17","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1115824573","media":"Tiger Newspress","summary":"U.S. stock index futures jumped on Monday as investors rushed in to take advantage of steep virus-dr","content":"<p>U.S. stock index futures jumped on Monday as investors rushed in to take advantage of steep virus-driven losses while awaiting more details on the severity of the Omicron coronavirus variant.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 226 points, or 0.65%. S&amp;P 500 e-minis were up 37 points, or 0.81% and Nasdaq 100 e-minis were up 148.75 points, or 0.93%.</p>\n<p><img src=\"https://static.tigerbbs.com/4e047384eb051a409672b8ce439d9f38\" tg-width=\"1080\" tg-height=\"392\" referrerpolicy=\"no-referrer\"></p>\n<p>Wall Street indexes had slumped between 2% and 3.5% on Friday after news of the variant triggered a global selloff, as countries introduced new travel curbs on fears it could resist vaccinations and upend a nascent economic reopening.</p>\n<p>President Joe Biden is due to update the public on the variant and the United States' response later in the day, the White House said.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Moderna</b>&nbsp;— Shares of the vaccine maker continued their rally, jumping more than 10% in early morning trading Monday after gaining 20% on Friday. On Sunday the company’s chief medical officer said Moderna&nbsp;could roll out a reformulated vaccine&nbsp;against the omicron variant of Covid early next year.</p>\n<p><b>Li Auto</b> —&nbsp;U.S.-listed shares of Li Auto rose 8.5%&nbsp;in premarket trading. Li Auto&nbsp;reported adjusted earnings of 3 cents a share from $1.21 billion in sales. Wall Street was looking for a 3-cent loss from $1.13 billion in sales. At this point, earnings are less important that sales for Li. The company is still growing rapidly. Sales in the third quarter rose more than 209% year over year.</p>\n<p><b>Tesla</b>&nbsp;—&nbsp;The German automotive news outlet Automobilwoche&nbsp;reported Monday that Tesla’s new manufacturing facility in that country will start production in December.Tesla&nbsp;shares&nbsp;rallied&nbsp;1.5%&nbsp;in premarket trading.</p>\n<p><b>Apple</b>&nbsp;—&nbsp;Apple&nbsp;rose 1.5% after HSBC raised its price target on the iPhone maker's stock.</p>\n<p><b>Airlines</b> — Major airlines ticked up as investors bought the dip following&nbsp;new travel suspensions in Asia and Europe, in response to the newly discovered omicron variant of Covid-19.United,Delta&nbsp;and&nbsp;American Airlines&nbsp;each gained about 1%, after losing about 7% Friday. Travel booking site&nbsp;Expedia&nbsp;also rose, about 2%.</p>\n<p><b>Cruise lines</b> —Carnival,Royal Caribbean Cruises&nbsp;and&nbsp;Norwegian Cruise Line Holdings&nbsp;each rose more than 3% amid the broader rebound in travel stocks from Friday’s omicron-driven sell-off.</p>\n<p><b>Allbirds</b>— Shares of the shoe manufacturer rose 2.5% after several analysts initiated coverage of the stock. Morgan Stanley and Bank of America both posted a price target of $23, implying 16% upside to Friday’s close.</p>\n<p><b>Coinbase</b>— The cryptocurrency exchange’s shares rose more than 2% as the price of bitcoin rebounded, after selling off with the broader equities market on Friday. Other crypto-related equities got a lift too, with&nbsp;Microstrategy&nbsp;rising 3.4%.Tesla&nbsp;and&nbsp;Square&nbsp;added more than 1%.</p>\n<p><b>Zoom Video</b>— Zoom shares fell almost 2%, moving in the opposite direction of travel stocks and following a 5.7% jump on Friday. Other stay-at-home stocks dipped slightly Monday morning too, including&nbsp;Peloton,Netflix&nbsp;and&nbsp;Teladoc.</p>\n<p><b>Merck</b>— The pharmaceutical company’s shares fell 1.8% after Citi downgraded its stock to neutral from buy, saying development struggles for the company’s HIV drug islatravir will hurt Merck’s long-term potential.</p>\n<p><b>Wynn Resorts,Las Vegas Sands</b>— The Macao gaming sector is lower after Alvin Chau, the head of Macau’s biggest casino junket operator, and 10 others were arrested over allegedly illegal gambling platforms targeting mainland Chinese, according to a report by the South China Morning Post.Wynn&nbsp;fell 1.9% and&nbsp;Las Vegas Sands&nbsp;fell 1.2%</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-29 21:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures jumped on Monday as investors rushed in to take advantage of steep virus-driven losses while awaiting more details on the severity of the Omicron coronavirus variant.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 226 points, or 0.65%. S&amp;P 500 e-minis were up 37 points, or 0.81% and Nasdaq 100 e-minis were up 148.75 points, or 0.93%.</p>\n<p><img src=\"https://static.tigerbbs.com/4e047384eb051a409672b8ce439d9f38\" tg-width=\"1080\" tg-height=\"392\" referrerpolicy=\"no-referrer\"></p>\n<p>Wall Street indexes had slumped between 2% and 3.5% on Friday after news of the variant triggered a global selloff, as countries introduced new travel curbs on fears it could resist vaccinations and upend a nascent economic reopening.</p>\n<p>President Joe Biden is due to update the public on the variant and the United States' response later in the day, the White House said.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Moderna</b>&nbsp;— Shares of the vaccine maker continued their rally, jumping more than 10% in early morning trading Monday after gaining 20% on Friday. On Sunday the company’s chief medical officer said Moderna&nbsp;could roll out a reformulated vaccine&nbsp;against the omicron variant of Covid early next year.</p>\n<p><b>Li Auto</b> —&nbsp;U.S.-listed shares of Li Auto rose 8.5%&nbsp;in premarket trading. Li Auto&nbsp;reported adjusted earnings of 3 cents a share from $1.21 billion in sales. Wall Street was looking for a 3-cent loss from $1.13 billion in sales. At this point, earnings are less important that sales for Li. The company is still growing rapidly. Sales in the third quarter rose more than 209% year over year.</p>\n<p><b>Tesla</b>&nbsp;—&nbsp;The German automotive news outlet Automobilwoche&nbsp;reported Monday that Tesla’s new manufacturing facility in that country will start production in December.Tesla&nbsp;shares&nbsp;rallied&nbsp;1.5%&nbsp;in premarket trading.</p>\n<p><b>Apple</b>&nbsp;—&nbsp;Apple&nbsp;rose 1.5% after HSBC raised its price target on the iPhone maker's stock.</p>\n<p><b>Airlines</b> — Major airlines ticked up as investors bought the dip following&nbsp;new travel suspensions in Asia and Europe, in response to the newly discovered omicron variant of Covid-19.United,Delta&nbsp;and&nbsp;American Airlines&nbsp;each gained about 1%, after losing about 7% Friday. Travel booking site&nbsp;Expedia&nbsp;also rose, about 2%.</p>\n<p><b>Cruise lines</b> —Carnival,Royal Caribbean Cruises&nbsp;and&nbsp;Norwegian Cruise Line Holdings&nbsp;each rose more than 3% amid the broader rebound in travel stocks from Friday’s omicron-driven sell-off.</p>\n<p><b>Allbirds</b>— Shares of the shoe manufacturer rose 2.5% after several analysts initiated coverage of the stock. Morgan Stanley and Bank of America both posted a price target of $23, implying 16% upside to Friday’s close.</p>\n<p><b>Coinbase</b>— The cryptocurrency exchange’s shares rose more than 2% as the price of bitcoin rebounded, after selling off with the broader equities market on Friday. Other crypto-related equities got a lift too, with&nbsp;Microstrategy&nbsp;rising 3.4%.Tesla&nbsp;and&nbsp;Square&nbsp;added more than 1%.</p>\n<p><b>Zoom Video</b>— Zoom shares fell almost 2%, moving in the opposite direction of travel stocks and following a 5.7% jump on Friday. Other stay-at-home stocks dipped slightly Monday morning too, including&nbsp;Peloton,Netflix&nbsp;and&nbsp;Teladoc.</p>\n<p><b>Merck</b>— The pharmaceutical company’s shares fell 1.8% after Citi downgraded its stock to neutral from buy, saying development struggles for the company’s HIV drug islatravir will hurt Merck’s long-term potential.</p>\n<p><b>Wynn Resorts,Las Vegas Sands</b>— The Macao gaming sector is lower after Alvin Chau, the head of Macau’s biggest casino junket operator, and 10 others were arrested over allegedly illegal gambling platforms targeting mainland Chinese, according to a report by the South China Morning Post.Wynn&nbsp;fell 1.9% and&nbsp;Las Vegas Sands&nbsp;fell 1.2%</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CCL":"嘉年华邮轮","LVS":"金沙集团","NCLH":"挪威邮轮","MRK":"默沙东","AAPL":"苹果","UAL":"联合大陆航空","BIRD":"Allbirds, Inc.","COIN":"Coinbase Global, Inc.","RCL":"皇家加勒比邮轮",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","AAL":"美国航空","LI":"理想汽车","ZM":"Zoom",".SPX":"S&P 500 Index","WYNN":"永利度假村","DAL":"达美航空","TSLA":"特斯拉","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115824573","content_text":"U.S. stock index futures jumped on Monday as investors rushed in to take advantage of steep virus-driven losses while awaiting more details on the severity of the Omicron coronavirus variant.\nAt 8:00 a.m. ET, Dow e-minis were up 226 points, or 0.65%. S&P 500 e-minis were up 37 points, or 0.81% and Nasdaq 100 e-minis were up 148.75 points, or 0.93%.\n\nWall Street indexes had slumped between 2% and 3.5% on Friday after news of the variant triggered a global selloff, as countries introduced new travel curbs on fears it could resist vaccinations and upend a nascent economic reopening.\nPresident Joe Biden is due to update the public on the variant and the United States' response later in the day, the White House said.\nStocks making the biggest moves premarket:\nModerna — Shares of the vaccine maker continued their rally, jumping more than 10% in early morning trading Monday after gaining 20% on Friday. On Sunday the company’s chief medical officer said Moderna could roll out a reformulated vaccine against the omicron variant of Covid early next year.\nLi Auto — U.S.-listed shares of Li Auto rose 8.5% in premarket trading. Li Auto reported adjusted earnings of 3 cents a share from $1.21 billion in sales. Wall Street was looking for a 3-cent loss from $1.13 billion in sales. At this point, earnings are less important that sales for Li. The company is still growing rapidly. Sales in the third quarter rose more than 209% year over year.\nTesla — The German automotive news outlet Automobilwoche reported Monday that Tesla’s new manufacturing facility in that country will start production in December.Tesla shares rallied 1.5% in premarket trading.\nApple — Apple rose 1.5% after HSBC raised its price target on the iPhone maker's stock.\nAirlines — Major airlines ticked up as investors bought the dip following new travel suspensions in Asia and Europe, in response to the newly discovered omicron variant of Covid-19.United,Delta and American Airlines each gained about 1%, after losing about 7% Friday. Travel booking site Expedia also rose, about 2%.\nCruise lines —Carnival,Royal Caribbean Cruises and Norwegian Cruise Line Holdings each rose more than 3% amid the broader rebound in travel stocks from Friday’s omicron-driven sell-off.\nAllbirds— Shares of the shoe manufacturer rose 2.5% after several analysts initiated coverage of the stock. Morgan Stanley and Bank of America both posted a price target of $23, implying 16% upside to Friday’s close.\nCoinbase— The cryptocurrency exchange’s shares rose more than 2% as the price of bitcoin rebounded, after selling off with the broader equities market on Friday. Other crypto-related equities got a lift too, with Microstrategy rising 3.4%.Tesla and Square added more than 1%.\nZoom Video— Zoom shares fell almost 2%, moving in the opposite direction of travel stocks and following a 5.7% jump on Friday. Other stay-at-home stocks dipped slightly Monday morning too, including Peloton,Netflix and Teladoc.\nMerck— The pharmaceutical company’s shares fell 1.8% after Citi downgraded its stock to neutral from buy, saying development struggles for the company’s HIV drug islatravir will hurt Merck’s long-term potential.\nWynn Resorts,Las Vegas Sands— The Macao gaming sector is lower after Alvin Chau, the head of Macau’s biggest casino junket operator, and 10 others were arrested over allegedly illegal gambling platforms targeting mainland Chinese, according to a report by the South China Morning Post.Wynn fell 1.9% and Las Vegas Sands fell 1.2%","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AAL":0.9,"AAPL":0.9,"BIRD":0.9,"CCL":0.9,"COIN":0.9,"DAL":0.9,"ESmain":0.9,"NQmain":0.9,"YMmain":0.9,"LI":0.9,"LVS":0.9,"MRK":0.9,"MRNA":0.9,"NCLH":0.9,"RCL":0.9,"TSLA":0.9,"UAL":0.9,"WYNN":0.9,"ZM":0.9}},"isVote":1,"tweetType":1,"viewCount":1787,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600498532,"gmtCreate":1638183100727,"gmtModify":1638183100891,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Thanks&nbsp;","listText":"Thanks&nbsp;","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600498532","repostId":"1193304775","repostType":4,"repost":{"id":"1193304775","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1638178459,"share":"https://ttm.financial/m/news/1193304775?lang=&edition=full","pubTime":"2021-11-29 17:34","market":"us","language":"en","title":"5 Stocks To Watch For November 29, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1193304775","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\nLi Auto's Q3 results beat estimates.its ","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Li Auto's Q3 results beat estimates.its&nbsp;total revenues reached $1.21 billion;deliveries reached 25,116 vehicles;gross margin reached 23.3%.Wall Street expects&nbsp;<b>Li Auto Inc.</b>&nbsp;to report a quarterly loss at $0.02 per share on revenue of $1.16 billion before the opening bell. Li Auto shares rose 5.8% to $34.29 in premarket trading&nbsp;Monday.</li>\n <li><b>Moderna, Inc.</b>, which was the second biopharma company to get authorization for a COVID-19 vaccine, is confident it will have something on the table shortly to tackle the latest virus threat. The company’s current vaccine will be tested against the new variant, and its ability to offer immunity will likely be known over the next couple of weeks, the company's chief medical officer Paul Burton reportedly said on BBC's \"Andrew Marr Show.\" Moderna shares rose 10.2% to $363.3 in premarket tradingMonday.</li>\n <li>Analysts are expecting&nbsp;<b>StoneX Group Inc.</b>&nbsp;to have earned $1.44 per share on revenue of $280.55 million for the latest quarter. The company will release earnings after the closing bell. StoneX shares dropped 3.4% to close at $66.70 on Friday.</li>\n</ul>\n<ul>\n <li><b>Tesla, Inc</b>&nbsp;will likely commence production operations at its Giga Berlin in Germany in December, Bloomberg reported, citing German magazine Automobilwoche. Tesla shares rallied more&nbsp;than&nbsp;2% to $1,106.2 in premarket tradingMonday.</li>\n <li>Frontline's Q3 results missed estimates.Analysts expect&nbsp;<b>Frontline Ltd.</b>&nbsp;to post a quarterly loss at $1.58 per share on revenue of $605.57 million before the opening bell. Frontline shares dropped 2.8% to&nbsp;$6.61 in premarket tradingMonday.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For November 29, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For November 29, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-11-29 17:34</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Li Auto's Q3 results beat estimates.its&nbsp;total revenues reached $1.21 billion;deliveries reached 25,116 vehicles;gross margin reached 23.3%.Wall Street expects&nbsp;<b>Li Auto Inc.</b>&nbsp;to report a quarterly loss at $0.02 per share on revenue of $1.16 billion before the opening bell. Li Auto shares rose 5.8% to $34.29 in premarket trading&nbsp;Monday.</li>\n <li><b>Moderna, Inc.</b>, which was the second biopharma company to get authorization for a COVID-19 vaccine, is confident it will have something on the table shortly to tackle the latest virus threat. The company’s current vaccine will be tested against the new variant, and its ability to offer immunity will likely be known over the next couple of weeks, the company's chief medical officer Paul Burton reportedly said on BBC's \"Andrew Marr Show.\" Moderna shares rose 10.2% to $363.3 in premarket tradingMonday.</li>\n <li>Analysts are expecting&nbsp;<b>StoneX Group Inc.</b>&nbsp;to have earned $1.44 per share on revenue of $280.55 million for the latest quarter. The company will release earnings after the closing bell. StoneX shares dropped 3.4% to close at $66.70 on Friday.</li>\n</ul>\n<ul>\n <li><b>Tesla, Inc</b>&nbsp;will likely commence production operations at its Giga Berlin in Germany in December, Bloomberg reported, citing German magazine Automobilwoche. Tesla shares rallied more&nbsp;than&nbsp;2% to $1,106.2 in premarket tradingMonday.</li>\n <li>Frontline's Q3 results missed estimates.Analysts expect&nbsp;<b>Frontline Ltd.</b>&nbsp;to post a quarterly loss at $1.58 per share on revenue of $605.57 million before the opening bell. Frontline shares dropped 2.8% to&nbsp;$6.61 in premarket tradingMonday.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车","MRNA":"Moderna, Inc.","SNEX":"StoneX Group Inc.","TSLA":"特斯拉","FRO":"FRONTLINE PLC"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193304775","content_text":"Some of the stocks that may grab investor focus today are:\n\nLi Auto's Q3 results beat estimates.its total revenues reached $1.21 billion;deliveries reached 25,116 vehicles;gross margin reached 23.3%.Wall Street expects Li Auto Inc. to report a quarterly loss at $0.02 per share on revenue of $1.16 billion before the opening bell. Li Auto shares rose 5.8% to $34.29 in premarket trading Monday.\nModerna, Inc., which was the second biopharma company to get authorization for a COVID-19 vaccine, is confident it will have something on the table shortly to tackle the latest virus threat. The company’s current vaccine will be tested against the new variant, and its ability to offer immunity will likely be known over the next couple of weeks, the company's chief medical officer Paul Burton reportedly said on BBC's \"Andrew Marr Show.\" Moderna shares rose 10.2% to $363.3 in premarket tradingMonday.\nAnalysts are expecting StoneX Group Inc. to have earned $1.44 per share on revenue of $280.55 million for the latest quarter. The company will release earnings after the closing bell. StoneX shares dropped 3.4% to close at $66.70 on Friday.\n\n\nTesla, Inc will likely commence production operations at its Giga Berlin in Germany in December, Bloomberg reported, citing German magazine Automobilwoche. Tesla shares rallied more than 2% to $1,106.2 in premarket tradingMonday.\nFrontline's Q3 results missed estimates.Analysts expect Frontline Ltd. to post a quarterly loss at $1.58 per share on revenue of $605.57 million before the opening bell. Frontline shares dropped 2.8% to $6.61 in premarket tradingMonday.","news_type":1,"symbols_score_info":{"FRO":0.9,"LI":0.9,"MRNA":0.9,"SNEX":0.9,"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":3047,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877409950,"gmtCreate":1637966463487,"gmtModify":1637966463586,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Good for who bought vaccine shares&nbsp;","listText":"Good for who bought vaccine shares&nbsp;","text":"Good for who bought vaccine shares","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877409950","repostId":"1125886564","repostType":4,"repost":{"id":"1125886564","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637938179,"share":"https://ttm.financial/m/news/1125886564?lang=&edition=full","pubTime":"2021-11-26 22:49","market":"us","language":"en","title":"Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1125886564","media":"Tiger Newspress","summary":"Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23% and BioNTech ","content":"<p>Vaccine&nbsp;stocks&nbsp;continued&nbsp;to&nbsp;rise&nbsp;in&nbsp;early&nbsp;trading,&nbsp;Moderna&nbsp;shares&nbsp;surged&nbsp;more&nbsp;than&nbsp;23%&nbsp;and&nbsp;BioNTech&nbsp;jumped&nbsp;nearly&nbsp;19%.<img src=\"https://static.tigerbbs.com/2e9f40662925ec57d0176cf5f1e36df4\" tg-width=\"876\" tg-height=\"613\" referrerpolicy=\"no-referrer\">Germany's BioNTech &nbsp;said it is studying the effectiveness of its COVID-19 vaccine against the new B.1.1.529 variant detected in South Africa - The Economic Times.</p>\n<p>\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" a BioNTech spokesperson said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-26 22:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine&nbsp;stocks&nbsp;continued&nbsp;to&nbsp;rise&nbsp;in&nbsp;early&nbsp;trading,&nbsp;Moderna&nbsp;shares&nbsp;surged&nbsp;more&nbsp;than&nbsp;23%&nbsp;and&nbsp;BioNTech&nbsp;jumped&nbsp;nearly&nbsp;19%.<img src=\"https://static.tigerbbs.com/2e9f40662925ec57d0176cf5f1e36df4\" tg-width=\"876\" tg-height=\"613\" referrerpolicy=\"no-referrer\">Germany's BioNTech &nbsp;said it is studying the effectiveness of its COVID-19 vaccine against the new B.1.1.529 variant detected in South Africa - The Economic Times.</p>\n<p>\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" a BioNTech spokesperson said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125886564","content_text":"Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23% and BioNTech jumped nearly 19%.Germany's BioNTech  said it is studying the effectiveness of its COVID-19 vaccine against the new B.1.1.529 variant detected in South Africa - The Economic Times.\n\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" a BioNTech spokesperson said.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":2061,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871156278,"gmtCreate":1637040752269,"gmtModify":1637040752269,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Thank&nbsp;you for the good read","listText":"Thank&nbsp;you for the good read","text":"Thank you for the good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871156278","repostId":"1160740007","repostType":4,"isVote":1,"tweetType":1,"viewCount":1061,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877863924,"gmtCreate":1637914268794,"gmtModify":1637914268859,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Oh no, new variant dramatic spike in cases. Please take care and stay safe my South African friends","listText":"Oh no, new variant dramatic spike in cases. Please take care and stay safe my South African friends","text":"Oh no, new variant dramatic spike in cases. Please take care and stay safe my South African friends","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877863924","repostId":"2186316305","repostType":4,"isVote":1,"tweetType":1,"viewCount":1774,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871105241,"gmtCreate":1637032749934,"gmtModify":1637032750090,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871105241","repostId":"1140879609","repostType":4,"isVote":1,"tweetType":1,"viewCount":741,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878651694,"gmtCreate":1637192185209,"gmtModify":1637192185310,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"[Sick]&nbsp;","listText":"[Sick]&nbsp;","text":"[Sick]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878651694","repostId":"2184764854","repostType":4,"isVote":1,"tweetType":1,"viewCount":865,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600652666,"gmtCreate":1638149944581,"gmtModify":1638149944706,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Been diving man!!!","listText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Been diving man!!!","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$Been diving man!!!","images":[{"img":"https://static.tigerbbs.com/891f0a3274e37f0627bc3d875fd913fa","width":"1125","height":"2312"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600652666","isVote":1,"tweetType":1,"viewCount":1921,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":876532687,"gmtCreate":1637330452218,"gmtModify":1637330452366,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Faster buy?","listText":"Faster buy?","text":"Faster buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876532687","repostId":"1138047553","repostType":4,"repost":{"id":"1138047553","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637327403,"share":"https://ttm.financial/m/news/1138047553?lang=&edition=full","pubTime":"2021-11-19 21:10","market":"us","language":"en","title":"Moderna Announces FDA Authorization of Booster Dose of COVID-19 Vaccine in the U.S. for Adults 18 Years and Older","url":"https://stock-news.laohu8.com/highlight/detail?id=1138047553","media":"Tiger Newspress","summary":"Moderna stock surged 4% in premarket trading after announcing FDA authorization of booster dose of C","content":"<p>Moderna stock surged 4% in premarket trading&nbsp;after announcing FDA authorization of booster dose of COVID-19 Vaccine in the U.S. for adults 18 years and older.</p>\n<p><img src=\"https://static.tigerbbs.com/b8db683899273d344e819a53f4b3366b\" tg-width=\"850\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna, Inc.&nbsp;today announced that theU.S. Food and Drug Administration(FDA) has extended the emergency use authorization of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level to all adults aged 18 and older. This booster can be used in all individuals 18 years and older who have completed a primary vaccination with any other authorized or approved COVID-19 vaccine.</p>\n<p>“This emergency use authorization comes at a critical time as we enter the winter months and face increasing COVID-19 case counts and hospitalizations across the country,” saidStéphane Bancel, Chief Executive Officer ofModerna. “We thank the FDA for their review, and are confident in the robust clinical evidence that a 50 µg booster dose of mRNA-1273 induces a strong immune response against COVID-19.”</p>\n<p>The booster dose is to be administered at least six months after completion of any primary series COVID-19 vaccination. OnOctober 20th, the FDAauthorizedfor emergency use a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level for people aged 65 and older as well as adults aged 18 to 64 who are at high risk of severe COVID-19; and people aged 18 to 64 with frequent institutional or occupational exposure to SARS-CoV-2. The Moderna COVID-19 booster vaccine is authorized for adults ages 18 and above regardless of occupational risk factors in many international markets. This follows the earlier approval of the 100 µg mRNA 1273 third dose in immunocompromised individuals.</p>\n<p>The FDA based this EUA on the totality of scientific evidence shared by the company including a data analysis from the Phase 2 clinical study of mRNA-1273, which was amended to offer a booster dose of mRNA-1273 at the 50 µg dose level to interested participants 6-8 months following their second dose (n=344). Neutralizing antibody titers had waned prior to boosting, particularly against variants of concern, at approximately 6 months. Notably, a booster dose of mRNA-1273 at the 50 µg dose level boosted neutralizing titers significantly above the Phase 3 benchmark. The safety profile following the booster dose was similar to that observed previously for dose 2 of mRNA-1273.</p>\n<p>As a next step, theU.S. Centers for Disease Controland Prevention’s (CDC)&nbsp;Advisory Committee on Immunization Practices(ACIP) will meet to discuss a potential recommendation for rollout of COVID-19 boosters to Americans.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Announces FDA Authorization of Booster Dose of COVID-19 Vaccine in the U.S. for Adults 18 Years and Older</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Announces FDA Authorization of Booster Dose of COVID-19 Vaccine in the U.S. for Adults 18 Years and Older\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-19 21:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna stock surged 4% in premarket trading&nbsp;after announcing FDA authorization of booster dose of COVID-19 Vaccine in the U.S. for adults 18 years and older.</p>\n<p><img src=\"https://static.tigerbbs.com/b8db683899273d344e819a53f4b3366b\" tg-width=\"850\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna, Inc.&nbsp;today announced that theU.S. Food and Drug Administration(FDA) has extended the emergency use authorization of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level to all adults aged 18 and older. This booster can be used in all individuals 18 years and older who have completed a primary vaccination with any other authorized or approved COVID-19 vaccine.</p>\n<p>“This emergency use authorization comes at a critical time as we enter the winter months and face increasing COVID-19 case counts and hospitalizations across the country,” saidStéphane Bancel, Chief Executive Officer ofModerna. “We thank the FDA for their review, and are confident in the robust clinical evidence that a 50 µg booster dose of mRNA-1273 induces a strong immune response against COVID-19.”</p>\n<p>The booster dose is to be administered at least six months after completion of any primary series COVID-19 vaccination. OnOctober 20th, the FDAauthorizedfor emergency use a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level for people aged 65 and older as well as adults aged 18 to 64 who are at high risk of severe COVID-19; and people aged 18 to 64 with frequent institutional or occupational exposure to SARS-CoV-2. The Moderna COVID-19 booster vaccine is authorized for adults ages 18 and above regardless of occupational risk factors in many international markets. This follows the earlier approval of the 100 µg mRNA 1273 third dose in immunocompromised individuals.</p>\n<p>The FDA based this EUA on the totality of scientific evidence shared by the company including a data analysis from the Phase 2 clinical study of mRNA-1273, which was amended to offer a booster dose of mRNA-1273 at the 50 µg dose level to interested participants 6-8 months following their second dose (n=344). Neutralizing antibody titers had waned prior to boosting, particularly against variants of concern, at approximately 6 months. Notably, a booster dose of mRNA-1273 at the 50 µg dose level boosted neutralizing titers significantly above the Phase 3 benchmark. The safety profile following the booster dose was similar to that observed previously for dose 2 of mRNA-1273.</p>\n<p>As a next step, theU.S. Centers for Disease Controland Prevention’s (CDC)&nbsp;Advisory Committee on Immunization Practices(ACIP) will meet to discuss a potential recommendation for rollout of COVID-19 boosters to Americans.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138047553","content_text":"Moderna stock surged 4% in premarket trading after announcing FDA authorization of booster dose of COVID-19 Vaccine in the U.S. for adults 18 years and older.\n\nModerna, Inc. today announced that theU.S. Food and Drug Administration(FDA) has extended the emergency use authorization of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level to all adults aged 18 and older. This booster can be used in all individuals 18 years and older who have completed a primary vaccination with any other authorized or approved COVID-19 vaccine.\n“This emergency use authorization comes at a critical time as we enter the winter months and face increasing COVID-19 case counts and hospitalizations across the country,” saidStéphane Bancel, Chief Executive Officer ofModerna. “We thank the FDA for their review, and are confident in the robust clinical evidence that a 50 µg booster dose of mRNA-1273 induces a strong immune response against COVID-19.”\nThe booster dose is to be administered at least six months after completion of any primary series COVID-19 vaccination. OnOctober 20th, the FDAauthorizedfor emergency use a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level for people aged 65 and older as well as adults aged 18 to 64 who are at high risk of severe COVID-19; and people aged 18 to 64 with frequent institutional or occupational exposure to SARS-CoV-2. The Moderna COVID-19 booster vaccine is authorized for adults ages 18 and above regardless of occupational risk factors in many international markets. This follows the earlier approval of the 100 µg mRNA 1273 third dose in immunocompromised individuals.\nThe FDA based this EUA on the totality of scientific evidence shared by the company including a data analysis from the Phase 2 clinical study of mRNA-1273, which was amended to offer a booster dose of mRNA-1273 at the 50 µg dose level to interested participants 6-8 months following their second dose (n=344). Neutralizing antibody titers had waned prior to boosting, particularly against variants of concern, at approximately 6 months. Notably, a booster dose of mRNA-1273 at the 50 µg dose level boosted neutralizing titers significantly above the Phase 3 benchmark. The safety profile following the booster dose was similar to that observed previously for dose 2 of mRNA-1273.\nAs a next step, theU.S. Centers for Disease Controland Prevention’s (CDC) Advisory Committee on Immunization Practices(ACIP) will meet to discuss a potential recommendation for rollout of COVID-19 boosters to Americans.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":1062,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876846042,"gmtCreate":1637295826622,"gmtModify":1637295826689,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Deep dip","listText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Deep dip","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$Deep dip","images":[{"img":"https://static.tigerbbs.com/8833b95dc4e27a2d444ee3da5cd24b0c","width":"1125","height":"2312"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876846042","isVote":1,"tweetType":1,"viewCount":390,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":878547201,"gmtCreate":1637212717752,"gmtModify":1637212728989,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Thanks for info","listText":"Thanks for info","text":"Thanks for info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878547201","repostId":"2184853339","repostType":4,"repost":{"id":"2184853339","kind":"highlight","pubTimestamp":1637206020,"share":"https://ttm.financial/m/news/2184853339?lang=&edition=full","pubTime":"2021-11-18 11:27","market":"us","language":"en","title":"Tired of Rivian and Lucid? 3 Better Growth Stocks to Buy Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2184853339","media":"Motley Fool","summary":"Electric vehicle stocks are hot, but these industrial companies could be better buys now.","content":"<p>With everything going on in the stock market and cryptocurrency market, it's hard for <a href=\"https://laohu8.com/S/AONE.U\">one</a> story to dominate headlines for a day, much less a week. Yet that's exactly what electric vehicle (EV) stocks have done since <b>Rivian Automotive</b> (NASDAQ:RIVN) had its initial public offering (IPO) last week. After debuting at a price of $78 per share, Rivian stock has already doubled. Similarly, share prices of <b>Lucid Group</b> (NASDAQ:LCID), a luxury EV company, have more than doubled in the last month. But those gains are in the past. It's time to look at what's the best option now.</p>\n<p>Investors scanning the horizon for growth stocks may be better off taking a look at <b>Trimble</b> (NASDAQ:TRMB), <b>Array Technologies </b>(NASDAQ:ARRY), and <b>MP Materials</b> (NYSE:MP). Here's why some Fool.com contributors think each is a great buy now.</p>\n<h2>The infrastructure bill is just one of many growth drivers for Trimble</h2>\n<p><b>Lee Samaha (Trimble):</b> Trimble is a leading light in the positioning and modeling business. As such, its roots lie in the geospatial industry (mapping and surveying). The geospatial industry is still a significant end market -- making up around 23% of Trimble's third-quarter revenue. However, its largest end market is buildings and construction (39% of revenue). The other two end markets are the fast-growing resources and utilities (20% of revenue) space and transportation (18% of revenue).</p>\n<p>Trimble's solutions are increasingly used as an integral part of its customers' daily activities. For example, trucking companies use Trimble to make sure their fleets are running safely and effectively, all the time analyzing real-time data to improve performance. In agriculture, its precision agriculture hardware and software help farmers make better decisions when it comes to planting, nurturing, and harvesting crops.</p>\n<p>Moreover, in building and construction, the company's technology helps contractors accurately complete building and infrastructure projects, and in doing so, reduce waste and carbon emissions. As such, the infrastructure bill will lead to plenty of growth opportunities as upgrading the nation's infrastructure can be achieved in a more cost-efficient and environmentally friendly way using Trimble.</p>\n<p>Given the explosion of connected devices, digital technologies, and analytics capability, it's highly likely that there will be increased adoption of positioning and modeling technology in the future. Again, Trimble is ideally placed to take advantage.</p>\n<h2>This solar stock went from cold to hot</h2>\n<p><b>Daniel Foelber&nbsp;(Array Technologies):</b> Share prices of solar tracking manufacturer Array Technologies have staged quite the comeback since falling 74% from its high in May. The company was caught completely off guard by supply chain constraints and rising raw material costs -- namely steel. The news not only stunted its growth, but crippled its margins, too.</p>\n<p>Although the company's short-term performance continues to suffer,&nbsp;it has done a good job partnering with companies like <b>Nucor</b> to secure more reliable steel pricing, as well as building a healthy backlog of projects. Although Array's Q3 figures were weak, the company's outlook for the year ahead casts a bright light that the worst of its problems may be over.</p>\n<p>Array is a great example of a growth stock that looked strong headed into 2021, suffered a lot of setbacks, and is now beginning to get back on its feet. Now is the perfect time for investors to revisit the long-term investment thesis, which centers around the growing need for more efficient and cost-effective solar tracking. Array's industry-leading technology maximizes the amount of solar energy that a panel can generate, which saves costs in the long run. The company's business is almost entirely in the U.S. but there are plans to expand internationally as new markets demand more efficient solar systems. Given the lower cost of utility-solar and estimates that solar will only grow its share in the global energy mix, Array is a growth stock worth following as its fundamentals improve.</p>\n<h2>Dig this under-the-radar EV stock</h2>\n<p><b>Scott Levine (MP Materials): </b>Soaring steeply higher in its short time as a publicly traded company, Rivian's stock is charging into the hearts -- and portfolios -- of many EV-focused investors. While the stock is currently the talk of the town, there's another EV stock that represents another great growth opportunity, though it hardly finds itself in the limelight as Rivian currently does. MP Materials is a mining company that owns and operates Mountain Pass, where it mines and processes rare earth minerals. Although lithium is the mineral that is likely most familiar to renewable energy investors, rare earth minerals are critical components in the production of magnets used in EVs and other advanced motion technologies like wind turbines and drones.</p>\n<p>The bull case for MP Materials is predicated largely on the fact that rare earth minerals are, well, <i>rare --&nbsp;</i>not something you can easily find in your backyard -- so owning and operating one of the largest integrated rare earth mining and processing facilities in the world (as MP Materials proclaims to do) is fairly compelling. Add to that the fact that the United States has voiced a desire to shore up its supply of rare earth materials by distancing itself from China, where the majority of rare earth minerals are currently sourced, and MP Materials becomes even more attractive.</p>\n<p>During an investors presentation last year, MP Materials projected that its revenue would rise at a compound annual growth rate (CAGR) of 53% from $75 million in 2019 to $415 million in 2023. But it wouldn't be surprising if the top line grows at an even greater clip than that. Through the first nine months of 2021, the company has reported revenue of $233 million, blowing past its earlier forecast of $171 million for all of 2021. Pivoting to the cash flow statement, investors will find that while this growth company has a long runway ahead of it, the company's risks are mitigated by the fact that it's cash-flow positive. Through the first nine months of 2021, MP Materials has generated operating cash flow of $70.5 million, and management expects it to become free-cash-flow positive in 2022.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tired of Rivian and Lucid? 3 Better Growth Stocks to Buy Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTired of Rivian and Lucid? 3 Better Growth Stocks to Buy Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-18 11:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/17/tired-of-rivian-and-lucid-3-better-growth-stocks-t/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With everything going on in the stock market and cryptocurrency market, it's hard for one story to dominate headlines for a day, much less a week. Yet that's exactly what electric vehicle (EV) stocks ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/17/tired-of-rivian-and-lucid-3-better-growth-stocks-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRMB":"天宝导航","ARRY":"Array Technologies Inc.","MP":"MP Materials Corp."},"source_url":"https://www.fool.com/investing/2021/11/17/tired-of-rivian-and-lucid-3-better-growth-stocks-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2184853339","content_text":"With everything going on in the stock market and cryptocurrency market, it's hard for one story to dominate headlines for a day, much less a week. Yet that's exactly what electric vehicle (EV) stocks have done since Rivian Automotive (NASDAQ:RIVN) had its initial public offering (IPO) last week. After debuting at a price of $78 per share, Rivian stock has already doubled. Similarly, share prices of Lucid Group (NASDAQ:LCID), a luxury EV company, have more than doubled in the last month. But those gains are in the past. It's time to look at what's the best option now.\nInvestors scanning the horizon for growth stocks may be better off taking a look at Trimble (NASDAQ:TRMB), Array Technologies (NASDAQ:ARRY), and MP Materials (NYSE:MP). Here's why some Fool.com contributors think each is a great buy now.\nThe infrastructure bill is just one of many growth drivers for Trimble\nLee Samaha (Trimble): Trimble is a leading light in the positioning and modeling business. As such, its roots lie in the geospatial industry (mapping and surveying). The geospatial industry is still a significant end market -- making up around 23% of Trimble's third-quarter revenue. However, its largest end market is buildings and construction (39% of revenue). The other two end markets are the fast-growing resources and utilities (20% of revenue) space and transportation (18% of revenue).\nTrimble's solutions are increasingly used as an integral part of its customers' daily activities. For example, trucking companies use Trimble to make sure their fleets are running safely and effectively, all the time analyzing real-time data to improve performance. In agriculture, its precision agriculture hardware and software help farmers make better decisions when it comes to planting, nurturing, and harvesting crops.\nMoreover, in building and construction, the company's technology helps contractors accurately complete building and infrastructure projects, and in doing so, reduce waste and carbon emissions. As such, the infrastructure bill will lead to plenty of growth opportunities as upgrading the nation's infrastructure can be achieved in a more cost-efficient and environmentally friendly way using Trimble.\nGiven the explosion of connected devices, digital technologies, and analytics capability, it's highly likely that there will be increased adoption of positioning and modeling technology in the future. Again, Trimble is ideally placed to take advantage.\nThis solar stock went from cold to hot\nDaniel Foelber (Array Technologies): Share prices of solar tracking manufacturer Array Technologies have staged quite the comeback since falling 74% from its high in May. The company was caught completely off guard by supply chain constraints and rising raw material costs -- namely steel. The news not only stunted its growth, but crippled its margins, too.\nAlthough the company's short-term performance continues to suffer, it has done a good job partnering with companies like Nucor to secure more reliable steel pricing, as well as building a healthy backlog of projects. Although Array's Q3 figures were weak, the company's outlook for the year ahead casts a bright light that the worst of its problems may be over.\nArray is a great example of a growth stock that looked strong headed into 2021, suffered a lot of setbacks, and is now beginning to get back on its feet. Now is the perfect time for investors to revisit the long-term investment thesis, which centers around the growing need for more efficient and cost-effective solar tracking. Array's industry-leading technology maximizes the amount of solar energy that a panel can generate, which saves costs in the long run. The company's business is almost entirely in the U.S. but there are plans to expand internationally as new markets demand more efficient solar systems. Given the lower cost of utility-solar and estimates that solar will only grow its share in the global energy mix, Array is a growth stock worth following as its fundamentals improve.\nDig this under-the-radar EV stock\nScott Levine (MP Materials): Soaring steeply higher in its short time as a publicly traded company, Rivian's stock is charging into the hearts -- and portfolios -- of many EV-focused investors. While the stock is currently the talk of the town, there's another EV stock that represents another great growth opportunity, though it hardly finds itself in the limelight as Rivian currently does. MP Materials is a mining company that owns and operates Mountain Pass, where it mines and processes rare earth minerals. Although lithium is the mineral that is likely most familiar to renewable energy investors, rare earth minerals are critical components in the production of magnets used in EVs and other advanced motion technologies like wind turbines and drones.\nThe bull case for MP Materials is predicated largely on the fact that rare earth minerals are, well, rare -- not something you can easily find in your backyard -- so owning and operating one of the largest integrated rare earth mining and processing facilities in the world (as MP Materials proclaims to do) is fairly compelling. Add to that the fact that the United States has voiced a desire to shore up its supply of rare earth materials by distancing itself from China, where the majority of rare earth minerals are currently sourced, and MP Materials becomes even more attractive.\nDuring an investors presentation last year, MP Materials projected that its revenue would rise at a compound annual growth rate (CAGR) of 53% from $75 million in 2019 to $415 million in 2023. But it wouldn't be surprising if the top line grows at an even greater clip than that. Through the first nine months of 2021, the company has reported revenue of $233 million, blowing past its earlier forecast of $171 million for all of 2021. Pivoting to the cash flow statement, investors will find that while this growth company has a long runway ahead of it, the company's risks are mitigated by the fact that it's cash-flow positive. Through the first nine months of 2021, MP Materials has generated operating cash flow of $70.5 million, and management expects it to become free-cash-flow positive in 2022.","news_type":1,"symbols_score_info":{"ARRY":0.9,"MP":0.9,"TRMB":0.9}},"isVote":1,"tweetType":1,"viewCount":842,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608655273,"gmtCreate":1638720881442,"gmtModify":1638720881598,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"[Smile]&nbsp;[Smile]&nbsp;","listText":"[Smile]&nbsp;[Smile]&nbsp;","text":"[Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608655273","repostId":"2188528084","repostType":4,"repost":{"id":"2188528084","kind":"highlight","pubTimestamp":1638543717,"share":"https://ttm.financial/m/news/2188528084?lang=&edition=full","pubTime":"2021-12-03 23:01","market":"us","language":"en","title":"5 Warren Buffett Stocks Are Screaming Buys in December","url":"https://stock-news.laohu8.com/highlight/detail?id=2188528084","media":"Motley Fool","summary":"Riding the Oracle of Omaha's coattails is often a moneymaking proposition.","content":"<p>Making money for shareholders has been in Warren Buffett's blood since taking over as CEO of <b>Berkshire Hathaway</b> (NYSE:BRK.A)(NYSE:BRK.B) in 1965. Over that time, he's led Berkshire to an average annual gain of about 20%, which translates into aggregate gains, including the year-to-date performance of the Class A shares (BRK.A), of approximately 3,500,000%. Gains like this are why the investing world pays close attention to what the Oracle of Omaha is buying and selling.</p>\n<p>Based on the latest 13F filing with the Securities and Exchange Commission, Berkshire Hathaway has stakes in 45 securities. Among these 45 holdings, five Warren Buffett stocks stand out as screaming buys in December.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e92116e97f06291ec28eda85974acb1b\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Berkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.</span></p>\n<h2>Amazon</h2>\n<p>While I'm well aware this isn't going to win any points for originality, e-commerce kingpin <b>Amazon</b> (NASDAQ:AMZN) remains a surefire stock to own in Buffett's portfolio.</p>\n<p>Most people are familiar with Amazon for its dominant online marketplace. According to an August report from eMarketer, Amazon is expected to handle 41.4% of all U.S. online sales in 2021. That's about 34 percentage points higher than the next-closest competitor. The key, though, is that the company has signed up 200 million people to a Prime membership worldwide. The annual fees collected from these members helps to buoy razor-thin retail margins and allows Amazon to consistently undercut brick-and-mortar retailers on price.</p>\n<p>However, the company's future rests with its considerably higher-margin segments, such as cloud infrastructure services. Amazon Web Services (AWS) accounted for only 13.4% of net sales in the third quarter, yet contributed 61.8% of the company's operating income. Even with online sales slowing as coronavirus vaccination rates tick higher and life returns to some semblance of normal, Amazon's critical highest-margin segments (AWS, subscriptions, and advertising) continue to grow rapidly.</p>\n<p>If Amazon were to simply hit the median price-to-operating cash flow it's been trading at for the past 11 years, we could be looking at a $10,000 a share company by mid-decade.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b18b49b2b35da2fc49e0a83b883d1c22\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Bristol Myers Squibb</h2>\n<p>Another Warren Buffett stock that's quickly become a screaming buy is pharmaceutical company <b>Bristol Myers Squibb</b> (NYSE:BMY).</p>\n<p>Bristol Myers' success is dependent on organically developing and growing its brand-name pharmaceutical portfolio, as well as leaning on acquisitions to push the needle higher.</p>\n<p>From an internal development perspective, some of the company's biggest wins include cancer immunotherapy Opdivo and oral anticoagulant Eliquis -- the latter of which was developed with <b>Pfizer</b>. Eliquis should push for $10 billion in sales for Bristol Myers this year, while Opdivo hit $7 billion in revenue last year. Opdivo is particularly intriguing given that it's being examined in dozens of clinical trials and has already received approval for 10 indications in the U.S. Label expansion opportunities, pricing power, and improved cancer screening diagnostics all have the potential to make this a $10 billion a year therapy.</p>\n<p>Bristol Myers also made waves with its November 2019 acquisition of cancer and immunology drugmaker Celgene. Buying Celgene added a handful of blockbuster drugs to Bristol's portfolio, including multiple myeloma treatment Revlimid, which will potentially top $13 billion in 2021 sales. Revlimid is protected from an onslaught of generic competition for four more years, which means Bristol Myers will be generating bountiful cash flow in the meantime.</p>\n<p>At just 7 times consensus forward-year earnings per share, it's an absolute steal.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a295212aa2b7c99c921b8afa2a4aa3a2\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/V\">Visa</a></h2>\n<p>The recent sell-off in payment processing behemoth <b>Visa</b> (NYSE:V) makes it a screaming buy, too.</p>\n<p>Over the past couple of months, Wall Street and investors have raised concerns about payment facilitators like <b>Square</b>&nbsp;or cryptocurrencies eating into Visa's dominance. However, these concerns seem unfounded given Visa's utter dominance of the processing space. As of 2018, it held a 53% share of U.S. credit card network purchase volume, which was more than 30 percentage points higher than the next-closest competitor. I should also mention the U.S. is the leading market for consumption in the world.</p>\n<p>Visa's outperformance is also a function of its lending avoidance. By sticking to the processing side of the equation, the company avoids having to set aside capital to cover credit delinquencies during recessions. Not having to cover credit/loan losses is a big reason why Visa rebounds faster than other financial stocks and maintains a profit margin north of 50%.</p>\n<p>And have I mentioned that Visa is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the smartest ways to play rapidly rising inflation? Since the company's fees are tied to the price of goods and services, its revenue and profits will grow as the price for goods and services rises.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1c5a0257bdd17a5ff3cf22a10de43ce0\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Teva Pharmaceutical Industries</h2>\n<p>The cheapest stock in Warren Buffett's portfolio, brand-name and generic-drug company <b>Teva Pharmaceutical Industries</b> (NYSE:TEVA), is begging to be bought as well. Teva can currently be purchased for a little more than 3 times Wall Street's consensus earnings per share in 2021 and 2022.</p>\n<p>Unlike Amazon, Bristol Myers, and Visa, Teva hasn't been firing on all cylinders. Since 2016, the company settled a bribery scandal, buried itself in debt after overpaying for generic-drugmaker Actavis, and has faced a mountain of litigation concerning its role in the opioid epidemic. But while there's reason to not give Teva a valuation premium, an earnings multiple of 3 is overly pessimistic given the steps being taken to right the ship.</p>\n<p>In late 2017, Kare Schultz took over as CEO. He's a turnaround specialist who's taken clear steps to improve the business. During his tenure, net debt has been reduced from over $34 billion to around $22 billion, and annual operating expenses have been cut by a double-digit percentage. Teva is leaner than it's been in years and is capable of maintaining annual operating cash flow of $2 billion (or higher).</p>\n<p>Furthermore, there's light at the end of the tunnel when it comes to opioid litigation. A trial in California recently went in favor of drugmakers, which could put some bargaining power back in Teva's court. If Schultz can negotiate a national settlement where free or reduced-cost medicine, not cash, is the lure, Teva could probably double very quickly.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7343c3ce7330b86321a8ec9384d4baea\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Bank of America</h2>\n<p>The final Warren Buffett stock to buy hand over fist in December is banking juggernaut <b>Bank of America</b> (NYSE:BAC).</p>\n<p>Bank stocks like BofA are on the cusp of hitting their growth sweet spot. With inflation picking up, the Federal Reserve will more than likely need to act in 2022 or 2023 to raise interest rates. Boosting the federal funds target rate will lift the net interest income-earning potential of banks with outstanding variable-rate loans.</p>\n<p>Among money-center banks, none is more interest-sensitive than Bank of America. The company's third-quarter earnings presentation points out that a 100-basis-point parallel shift in the interest rate yield curve would generate an estimated $7.2 billion in added net interest income over 12 months. Although we're unlikely to see a 100-basis-point shift in 12 months, we are on the verge of seeing higher interest rates significantly bolster BofA's profit potential.</p>\n<p>The other impressive aspect of Warren Buffett's second-largest holding is its digitization efforts. Though you probably don't think of Bank of America as a tech-savvy business, the number of digital active users has grown to nearly 41 million, with 43% of all sales in the third quarter coming from online or mobile banking. This push to digitize has allowed the company to consolidate some of its branches in order to reduce costs.</p>\n<p>Bank of America should be a no-brainer buy as it enters the sweet spot of its growth cycle.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Warren Buffett Stocks Are Screaming Buys in December</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Warren Buffett Stocks Are Screaming Buys in December\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/03/5-warren-buffett-stocks-screaming-buys-in-december/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Making money for shareholders has been in Warren Buffett's blood since taking over as CEO of Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) in 1965. Over that time, he's led Berkshire to an average ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/03/5-warren-buffett-stocks-screaming-buys-in-december/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4535":"淡马锡持仓","BK4106":"数据处理与外包服务","BK4557":"大麻股","BAC":"美国银行","BK4538":"云计算","BK4559":"巴菲特持仓","BK4504":"桥水持仓","V":"Visa","BK4550":"红杉资本持仓","BK4507":"流媒体概念","BK4548":"巴美列捷福持仓","BRK.B":"伯克希尔B","BK4007":"制药","BK4551":"寇图资本持仓","BK4207":"综合性银行","BMY":"施贵宝","BK4561":"索罗斯持仓","BK4524":"宅经济概念","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","TEVA":"梯瓦制药","BK4527":"明星科技股","BK4553":"喜马拉雅资本持仓","BRK.A":"伯克希尔","BK4534":"瑞士信贷持仓","BK4503":"景林资产持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4122":"互联网与直销零售","BK4176":"多领域控股","BK4566":"资本集团","AMZN":"亚马逊"},"source_url":"https://www.fool.com/investing/2021/12/03/5-warren-buffett-stocks-screaming-buys-in-december/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188528084","content_text":"Making money for shareholders has been in Warren Buffett's blood since taking over as CEO of Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) in 1965. Over that time, he's led Berkshire to an average annual gain of about 20%, which translates into aggregate gains, including the year-to-date performance of the Class A shares (BRK.A), of approximately 3,500,000%. Gains like this are why the investing world pays close attention to what the Oracle of Omaha is buying and selling.\nBased on the latest 13F filing with the Securities and Exchange Commission, Berkshire Hathaway has stakes in 45 securities. Among these 45 holdings, five Warren Buffett stocks stand out as screaming buys in December.\nBerkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.\nAmazon\nWhile I'm well aware this isn't going to win any points for originality, e-commerce kingpin Amazon (NASDAQ:AMZN) remains a surefire stock to own in Buffett's portfolio.\nMost people are familiar with Amazon for its dominant online marketplace. According to an August report from eMarketer, Amazon is expected to handle 41.4% of all U.S. online sales in 2021. That's about 34 percentage points higher than the next-closest competitor. The key, though, is that the company has signed up 200 million people to a Prime membership worldwide. The annual fees collected from these members helps to buoy razor-thin retail margins and allows Amazon to consistently undercut brick-and-mortar retailers on price.\nHowever, the company's future rests with its considerably higher-margin segments, such as cloud infrastructure services. Amazon Web Services (AWS) accounted for only 13.4% of net sales in the third quarter, yet contributed 61.8% of the company's operating income. Even with online sales slowing as coronavirus vaccination rates tick higher and life returns to some semblance of normal, Amazon's critical highest-margin segments (AWS, subscriptions, and advertising) continue to grow rapidly.\nIf Amazon were to simply hit the median price-to-operating cash flow it's been trading at for the past 11 years, we could be looking at a $10,000 a share company by mid-decade.\nImage source: Getty Images.\nBristol Myers Squibb\nAnother Warren Buffett stock that's quickly become a screaming buy is pharmaceutical company Bristol Myers Squibb (NYSE:BMY).\nBristol Myers' success is dependent on organically developing and growing its brand-name pharmaceutical portfolio, as well as leaning on acquisitions to push the needle higher.\nFrom an internal development perspective, some of the company's biggest wins include cancer immunotherapy Opdivo and oral anticoagulant Eliquis -- the latter of which was developed with Pfizer. Eliquis should push for $10 billion in sales for Bristol Myers this year, while Opdivo hit $7 billion in revenue last year. Opdivo is particularly intriguing given that it's being examined in dozens of clinical trials and has already received approval for 10 indications in the U.S. Label expansion opportunities, pricing power, and improved cancer screening diagnostics all have the potential to make this a $10 billion a year therapy.\nBristol Myers also made waves with its November 2019 acquisition of cancer and immunology drugmaker Celgene. Buying Celgene added a handful of blockbuster drugs to Bristol's portfolio, including multiple myeloma treatment Revlimid, which will potentially top $13 billion in 2021 sales. Revlimid is protected from an onslaught of generic competition for four more years, which means Bristol Myers will be generating bountiful cash flow in the meantime.\nAt just 7 times consensus forward-year earnings per share, it's an absolute steal.\nImage source: Getty Images.\nVisa\nThe recent sell-off in payment processing behemoth Visa (NYSE:V) makes it a screaming buy, too.\nOver the past couple of months, Wall Street and investors have raised concerns about payment facilitators like Square or cryptocurrencies eating into Visa's dominance. However, these concerns seem unfounded given Visa's utter dominance of the processing space. As of 2018, it held a 53% share of U.S. credit card network purchase volume, which was more than 30 percentage points higher than the next-closest competitor. I should also mention the U.S. is the leading market for consumption in the world.\nVisa's outperformance is also a function of its lending avoidance. By sticking to the processing side of the equation, the company avoids having to set aside capital to cover credit delinquencies during recessions. Not having to cover credit/loan losses is a big reason why Visa rebounds faster than other financial stocks and maintains a profit margin north of 50%.\nAnd have I mentioned that Visa is one of the smartest ways to play rapidly rising inflation? Since the company's fees are tied to the price of goods and services, its revenue and profits will grow as the price for goods and services rises.\nImage source: Getty Images.\nTeva Pharmaceutical Industries\nThe cheapest stock in Warren Buffett's portfolio, brand-name and generic-drug company Teva Pharmaceutical Industries (NYSE:TEVA), is begging to be bought as well. Teva can currently be purchased for a little more than 3 times Wall Street's consensus earnings per share in 2021 and 2022.\nUnlike Amazon, Bristol Myers, and Visa, Teva hasn't been firing on all cylinders. Since 2016, the company settled a bribery scandal, buried itself in debt after overpaying for generic-drugmaker Actavis, and has faced a mountain of litigation concerning its role in the opioid epidemic. But while there's reason to not give Teva a valuation premium, an earnings multiple of 3 is overly pessimistic given the steps being taken to right the ship.\nIn late 2017, Kare Schultz took over as CEO. He's a turnaround specialist who's taken clear steps to improve the business. During his tenure, net debt has been reduced from over $34 billion to around $22 billion, and annual operating expenses have been cut by a double-digit percentage. Teva is leaner than it's been in years and is capable of maintaining annual operating cash flow of $2 billion (or higher).\nFurthermore, there's light at the end of the tunnel when it comes to opioid litigation. A trial in California recently went in favor of drugmakers, which could put some bargaining power back in Teva's court. If Schultz can negotiate a national settlement where free or reduced-cost medicine, not cash, is the lure, Teva could probably double very quickly.\nImage source: Getty Images.\nBank of America\nThe final Warren Buffett stock to buy hand over fist in December is banking juggernaut Bank of America (NYSE:BAC).\nBank stocks like BofA are on the cusp of hitting their growth sweet spot. With inflation picking up, the Federal Reserve will more than likely need to act in 2022 or 2023 to raise interest rates. Boosting the federal funds target rate will lift the net interest income-earning potential of banks with outstanding variable-rate loans.\nAmong money-center banks, none is more interest-sensitive than Bank of America. The company's third-quarter earnings presentation points out that a 100-basis-point parallel shift in the interest rate yield curve would generate an estimated $7.2 billion in added net interest income over 12 months. Although we're unlikely to see a 100-basis-point shift in 12 months, we are on the verge of seeing higher interest rates significantly bolster BofA's profit potential.\nThe other impressive aspect of Warren Buffett's second-largest holding is its digitization efforts. Though you probably don't think of Bank of America as a tech-savvy business, the number of digital active users has grown to nearly 41 million, with 43% of all sales in the third quarter coming from online or mobile banking. This push to digitize has allowed the company to consolidate some of its branches in order to reduce costs.\nBank of America should be a no-brainer buy as it enters the sweet spot of its growth cycle.","news_type":1,"symbols_score_info":{"AMZN":0.9,"BAC":0.9,"BMY":0.9,"BRK.A":0.9,"BRK.B":0.9,"TEVA":0.9,"V":0.9}},"isVote":1,"tweetType":1,"viewCount":1942,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877076195,"gmtCreate":1637852078062,"gmtModify":1637852078167,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877076195","repostId":"1119170686","repostType":4,"isVote":1,"tweetType":1,"viewCount":2017,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874811472,"gmtCreate":1637755650998,"gmtModify":1637755651064,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>It’s time, now or never","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>It’s time, now or never","text":"$Alibaba(BABA)$It’s time, now or never","images":[{"img":"https://static.tigerbbs.com/d6e05e9e34db0343fa31df5b96c9ac83","width":"1125","height":"3138"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874811472","isVote":1,"tweetType":1,"viewCount":519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":875159397,"gmtCreate":1637627069416,"gmtModify":1637627069502,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NIO\">$NIO Inc.(NIO)$</a>Earning for nasi lemak","listText":"<a href=\"https://laohu8.com/S/NIO\">$NIO Inc.(NIO)$</a>Earning for nasi lemak","text":"$NIO Inc.(NIO)$Earning for nasi lemak","images":[{"img":"https://static.tigerbbs.com/ed77cae44f1f18fcb3c372b35d067e09","width":"1170","height":"2292"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875159397","isVote":1,"tweetType":1,"viewCount":646,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":873783825,"gmtCreate":1636987256492,"gmtModify":1636987256562,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Have done my first buy, omg. Haha","listText":"Have done my first buy, omg. Haha","text":"Have done my first buy, omg. Haha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873783825","isVote":1,"tweetType":1,"viewCount":193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603972346,"gmtCreate":1638360106895,"gmtModify":1638360107104,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"[Miser]&nbsp;","listText":"[Miser]&nbsp;","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603972346","repostId":"1180779617","repostType":4,"repost":{"id":"1180779617","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638349549,"share":"https://ttm.financial/m/news/1180779617?lang=&edition=full","pubTime":"2021-12-01 17:05","market":"us","language":"en","title":"NIO and Li Auto stocks jumped 5% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1180779617","media":"Tiger Newspress","summary":"NIO and Li Auto stocks jumped 5% in premarket trading after announcing bright delivery data.\n\nNIO de","content":"<p>NIO and Li Auto stocks jumped 5% in premarket trading after announcing bright delivery data.</p>\n<p><img src=\"https://static.tigerbbs.com/1fd7888d67848b24b5db338e59e75b97\" tg-width=\"853\" tg-height=\"623\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/51d2f8b4ca69c88da235c91213c41ab6\" tg-width=\"853\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p>\n<p>NIO delivered 10,878 vehicles in November 2021, representing a solid 105.6% year-over-year growth. The deliveries consisted of 2,683 ES8s, the Company’s six- or seven-seater flagship premium smart electric SUV, 4,713 ES6s, the Company’s five-seater high-performance premium smart electric SUV, and 3,482 EC6s, the Company’s five-seater premium smart electric coupe SUV. NIO has delivered 80,940 vehicles year-to-date in 2021 in total, representing a strong increase of 120.4% year-over-year. As of November 30, 2021, cumulative deliveries of the ES8, ES6 and EC6 reached 156,581 vehicles.</p>\n<p>Li Auto Inc.&nbsp;today announced that the Company delivered 13,485 Li ONEs in November 2021, representing a 190.2% year-over-year increase. Total deliveries for the eleven months ended November 30, 2021 reached 76,404, taking cumulative deliveries to 110,001.</p>\n<p>“We set a new monthly record with over 13,000 deliveries of Li ONEs in November, making Li ONE the first domestic branded premium model&nbsp;priced above RMB300,000&nbsp;in China to achieve the 10,000 monthly deliveries milestone. We are excited to see Li ONE emerge as one of the best choices for large SUV users and families in China. This impressive result reflects widespread user endorsement of our outstanding product features and performance, and we deeply appreciate our users’ recognition. Looking ahead, we will continue to create products and services that can delight our users and make ourselves proud,” said Yanan Shen, co-founder and president of Li Auto.</p>\n<p>As of November 30, 2021, the Company had 174 retail stores in 93 cities, as well as 236 servicing centers and Li Auto-authorized body and paint shops operating in 171 cities.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO and Li Auto stocks jumped 5% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO and Li Auto stocks jumped 5% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-01 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NIO and Li Auto stocks jumped 5% in premarket trading after announcing bright delivery data.</p>\n<p><img src=\"https://static.tigerbbs.com/1fd7888d67848b24b5db338e59e75b97\" tg-width=\"853\" tg-height=\"623\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/51d2f8b4ca69c88da235c91213c41ab6\" tg-width=\"853\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p>\n<p>NIO delivered 10,878 vehicles in November 2021, representing a solid 105.6% year-over-year growth. The deliveries consisted of 2,683 ES8s, the Company’s six- or seven-seater flagship premium smart electric SUV, 4,713 ES6s, the Company’s five-seater high-performance premium smart electric SUV, and 3,482 EC6s, the Company’s five-seater premium smart electric coupe SUV. NIO has delivered 80,940 vehicles year-to-date in 2021 in total, representing a strong increase of 120.4% year-over-year. As of November 30, 2021, cumulative deliveries of the ES8, ES6 and EC6 reached 156,581 vehicles.</p>\n<p>Li Auto Inc.&nbsp;today announced that the Company delivered 13,485 Li ONEs in November 2021, representing a 190.2% year-over-year increase. Total deliveries for the eleven months ended November 30, 2021 reached 76,404, taking cumulative deliveries to 110,001.</p>\n<p>“We set a new monthly record with over 13,000 deliveries of Li ONEs in November, making Li ONE the first domestic branded premium model&nbsp;priced above RMB300,000&nbsp;in China to achieve the 10,000 monthly deliveries milestone. We are excited to see Li ONE emerge as one of the best choices for large SUV users and families in China. This impressive result reflects widespread user endorsement of our outstanding product features and performance, and we deeply appreciate our users’ recognition. Looking ahead, we will continue to create products and services that can delight our users and make ourselves proud,” said Yanan Shen, co-founder and president of Li Auto.</p>\n<p>As of November 30, 2021, the Company had 174 retail stores in 93 cities, as well as 236 servicing centers and Li Auto-authorized body and paint shops operating in 171 cities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车","NIO":"蔚来"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180779617","content_text":"NIO and Li Auto stocks jumped 5% in premarket trading after announcing bright delivery data.\n\nNIO delivered 10,878 vehicles in November 2021, representing a solid 105.6% year-over-year growth. The deliveries consisted of 2,683 ES8s, the Company’s six- or seven-seater flagship premium smart electric SUV, 4,713 ES6s, the Company’s five-seater high-performance premium smart electric SUV, and 3,482 EC6s, the Company’s five-seater premium smart electric coupe SUV. NIO has delivered 80,940 vehicles year-to-date in 2021 in total, representing a strong increase of 120.4% year-over-year. As of November 30, 2021, cumulative deliveries of the ES8, ES6 and EC6 reached 156,581 vehicles.\nLi Auto Inc. today announced that the Company delivered 13,485 Li ONEs in November 2021, representing a 190.2% year-over-year increase. Total deliveries for the eleven months ended November 30, 2021 reached 76,404, taking cumulative deliveries to 110,001.\n“We set a new monthly record with over 13,000 deliveries of Li ONEs in November, making Li ONE the first domestic branded premium model priced above RMB300,000 in China to achieve the 10,000 monthly deliveries milestone. We are excited to see Li ONE emerge as one of the best choices for large SUV users and families in China. This impressive result reflects widespread user endorsement of our outstanding product features and performance, and we deeply appreciate our users’ recognition. Looking ahead, we will continue to create products and services that can delight our users and make ourselves proud,” said Yanan Shen, co-founder and president of Li Auto.\nAs of November 30, 2021, the Company had 174 retail stores in 93 cities, as well as 236 servicing centers and Li Auto-authorized body and paint shops operating in 171 cities.","news_type":1,"symbols_score_info":{"LI":0.9,"NIO":0.9}},"isVote":1,"tweetType":1,"viewCount":2279,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877884326,"gmtCreate":1637913166079,"gmtModify":1637913166151,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"Ikr","listText":"Ikr","text":"Ikr","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877884326","repostId":"1132624780","repostType":2,"repost":{"id":"1132624780","kind":"news","pubTimestamp":1637910459,"share":"https://ttm.financial/m/news/1132624780?lang=&edition=full","pubTime":"2021-11-26 15:07","market":"sg","language":"en","title":"Singapore launches vaccinated travel lanes with Thailand, Cambodia, Fiji, Maldives, Sri Lanka and Turkey","url":"https://stock-news.laohu8.com/highlight/detail?id=1132624780","media":"CNA","summary":"Singapore will extend vaccinated travel lanes (VTLs) to six more countries next month, the Civil Avi","content":"<p>Singapore will extend vaccinated travel lanes (VTLs) to six more countries next month,&nbsp;the Civil Aviation Authority of Singapore (CAAS) announced on Friday (Nov 26).</p>\n<p>From Dec 14, travellers from Thailand may enter Singapore under the quarantine-free VTL.</p>\n<p>Travellers from&nbsp;Cambodia, Fiji, Maldives, Sri Lanka and Turkey can do so&nbsp;from Dec 16.</p>\n<p>This&nbsp;latest move will increase the number of countries with which Singapore has VTL arrangements to 27.</p>\n<p>Before the COVID-19 pandemic, these&nbsp;27 countries contributed to about 60 per cent of the total daily arrivals at Changi Airport, said CAAS.</p>\n<p>\"This latest extension will further broaden Changi’s network and help reclaim and rebuild Singapore's status as an international aviation hub with global connectivity,\" said the authority.</p>\n<p>Under the VTL scheme, fully vaccinated travellers on designated VTL flights&nbsp;can enter Singapore without undergoing quarantine. They are only required to undergo COVID-19 testing.</p>\n<p>\"The expansion of the VTL scheme to these countries will continue to restore two-way quarantine-free travel between Singapore and VTL countries whose borders are now open to us,\" said CAAS.</p>\n<p><b>RESTRICTIONS TIGHTENED FOR SOME COUNTRIES</b></p>\n<p>Singapore will classify&nbsp;Austria, Belgium, Croatia, the Czech Republic, Liechtenstein and Slovakia as Category III countries from 11.59pm on Dec 1, the Ministry of Health (MOH) said in a separate news release.</p>\n<p>This follows the \"worsening situation\" in the six European countries, MOH said.</p>\n<p>Travellers from Category III countries are required to serve a 10-day stay-home notice at their place of accommodation, in addition to COVID-19 testing.</p>","source":"can_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore launches vaccinated travel lanes with Thailand, Cambodia, Fiji, Maldives, Sri Lanka and Turkey</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore launches vaccinated travel lanes with Thailand, Cambodia, Fiji, Maldives, Sri Lanka and Turkey\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 15:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.channelnewsasia.com/singapore/vtl-thailand-cambodia-maldives-singapore-vaccinated-travel-lane-covid19-2340016><strong>CNA</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Singapore will extend vaccinated travel lanes (VTLs) to six more countries next month, the Civil Aviation Authority of Singapore (CAAS) announced on Friday (Nov 26).\nFrom Dec 14, travellers from ...</p>\n\n<a href=\"https://www.channelnewsasia.com/singapore/vtl-thailand-cambodia-maldives-singapore-vaccinated-travel-lane-covid19-2340016\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数","C6L.SI":"新加坡航空公司"},"source_url":"https://www.channelnewsasia.com/singapore/vtl-thailand-cambodia-maldives-singapore-vaccinated-travel-lane-covid19-2340016","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132624780","content_text":"Singapore will extend vaccinated travel lanes (VTLs) to six more countries next month, the Civil Aviation Authority of Singapore (CAAS) announced on Friday (Nov 26).\nFrom Dec 14, travellers from Thailand may enter Singapore under the quarantine-free VTL.\nTravellers from Cambodia, Fiji, Maldives, Sri Lanka and Turkey can do so from Dec 16.\nThis latest move will increase the number of countries with which Singapore has VTL arrangements to 27.\nBefore the COVID-19 pandemic, these 27 countries contributed to about 60 per cent of the total daily arrivals at Changi Airport, said CAAS.\n\"This latest extension will further broaden Changi’s network and help reclaim and rebuild Singapore's status as an international aviation hub with global connectivity,\" said the authority.\nUnder the VTL scheme, fully vaccinated travellers on designated VTL flights can enter Singapore without undergoing quarantine. They are only required to undergo COVID-19 testing.\n\"The expansion of the VTL scheme to these countries will continue to restore two-way quarantine-free travel between Singapore and VTL countries whose borders are now open to us,\" said CAAS.\nRESTRICTIONS TIGHTENED FOR SOME COUNTRIES\nSingapore will classify Austria, Belgium, Croatia, the Czech Republic, Liechtenstein and Slovakia as Category III countries from 11.59pm on Dec 1, the Ministry of Health (MOH) said in a separate news release.\nThis follows the \"worsening situation\" in the six European countries, MOH said.\nTravellers from Category III countries are required to serve a 10-day stay-home notice at their place of accommodation, in addition to COVID-19 testing.","news_type":1,"symbols_score_info":{"C6L.SI":0.9,"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":2140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874534427,"gmtCreate":1637800235986,"gmtModify":1637800241574,"author":{"id":"4099220912746340","authorId":"4099220912746340","name":"Sean.ndt","avatar":"https://static.tigerbbs.com/4e0e2031763bf346a39f664fa04c4b4a","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099220912746340","authorIdStr":"4099220912746340"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>Yeyyy","listText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>Yeyyy","text":"$AMD(AMD)$Yeyyy","images":[{"img":"https://static.tigerbbs.com/3873bf4e608fb5824cbc4ef85c2b6d50","width":"1125","height":"2877"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874534427","isVote":1,"tweetType":1,"viewCount":2651,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"lives":[]}